-DOCSTART- NN -X-

A DT O
27 CD B-Age
years NNS I-Age
old JJ I-Age
, , O
male NN O
, , O
right RB O
handed VBN O
, , O
was VBD O
admitted VBN O
for IN O
a DT O
2 CD B-Duration
years NNS I-Duration
history NN O
of IN O
very RB B-Detailed_description
frequent JJ I-Detailed_description
gelastic JJ B-Disease_disorder
seizures NNS I-Disease_disorder
. . O

The DT O
patient NN O
described VBD O
aura JJ B-Sign_symptom
- : I-Sign_symptom
like IN I-Sign_symptom
symptoms NNS I-Sign_symptom
: : O
especially RB O
warmth VBZ B-Sign_symptom
throughout IN O
the DT O
face NN B-Biological_structure
and CC O
dizziness NN B-Sign_symptom
that WDT O
preceded VBD O
the DT O
seizure NN B-Sign_symptom
and CC O
he PRP O
denied VBD O
any DT O
affective JJ B-Sign_symptom
connotation NN I-Sign_symptom
. . O

Some DT B-Detailed_description
of IN O
the DT O
seizures NNS B-Sign_symptom
consisted VBD O
only RB O
of IN O
a DT O
brief JJ B-Detailed_description
period NN O
of IN O
laughter NN B-Sign_symptom
without IN O
any DT O
motor NN B-Sign_symptom
involvement NN I-Sign_symptom
, , O
but CC O
a DT O
typical JJ O
seizure NN B-Sign_symptom
would MD O
consist VB O
of IN O
sudden JJ B-Detailed_description
laughter NN B-Sign_symptom
accompanied VBN O
by IN O
simple JJ B-Sign_symptom
motor NN I-Sign_symptom
partial JJ I-Sign_symptom
seizures NNS I-Sign_symptom
in IN O
both DT B-Biological_structure
arms NNS I-Biological_structure
, , O
more RBR O
often RB O
being VBG O
involved VBN O
his PRP$ O
left JJ B-Biological_structure
arm NN I-Biological_structure
, , O
without IN O
impairment NN B-Sign_symptom
of IN I-Sign_symptom
his PRP$ I-Sign_symptom
consciousness NN I-Sign_symptom
state NN I-Sign_symptom
, , O
which WDT O
lasted VBD O
less JJR B-Detailed_description
than IN I-Detailed_description
1 CD I-Detailed_description
minute NN I-Detailed_description
. . O

He PRP O
had VBD O
no DT O
previous JJ O
past NN O
medical JJ O
or CC O
social JJ O
history NN O
other JJ O
than IN O
being VBG O
a DT O
smoker NN O
: : O
10 CD B-Quantitative_concept
- : I-Quantitative_concept
15 CD I-Quantitative_concept
cigarettes NNS I-Quantitative_concept
per IN I-Quantitative_concept
day NN I-Quantitative_concept
. . O

The DT O
frequency NN O
of IN O
the DT O
seizures NNS B-Sign_symptom
was VBD O
initially RB B-Detailed_description
low JJ B-Frequency
, , O
but CC O
increased VBD B-Detailed_description
progressively RB I-Detailed_description
over IN I-Detailed_description
time NN I-Detailed_description
to TO O
about IN O
8 CD B-Frequency
- : I-Frequency
10 CD I-Frequency
seizures NNS I-Frequency
/ JJ I-Frequency
day NN I-Frequency
, , O
despite IN O
anti JJ B-Therapeutic_procedure
- : I-Therapeutic_procedure
epileptic JJ I-Therapeutic_procedure
treatment NN I-Therapeutic_procedure
- : O
at IN O
the DT O
time NN O
of IN O
admission NN O
he PRP O
was VBD O
taking VBG O
Keppra NNP B-Medication
- : O
Levetiracetam $ B-Medication
3 CD B-Dosage
x $ I-Dosage
250 CD I-Dosage
mg JJ I-Dosage
/ NNP I-Dosage
day NN I-Dosage
and CC O
Phenytoin NNP B-Medication
3 CD B-Dosage
x VBD I-Dosage
100 CD I-Dosage
mg JJ I-Dosage
/ NNP I-Dosage
day NN I-Dosage
. . O

With IN O
the DT O
Neurology NNP B-Nonbiological_location
Electrophysiology NNP I-Nonbiological_location
Department NNP I-Nonbiological_location
assistance NN O
we PRP O
have VBP O
been VBN O
able JJ O
to TO O
record VB O
a DT O
couple NN O
of IN O
seizures NNS B-Sign_symptom
on IN O
the DT O
Video NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
EEG NNP I-Diagnostic_procedure
His PRP$ O
neurological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
. . O

Diagnosis NN O
was VBD O
made VBN O
on IN O
native JJ B-Detailed_description
CT NNP B-Diagnostic_procedure
scan NN I-Diagnostic_procedure
: : O
minimal JJ B-Detailed_description
hypodense NN B-Detailed_description
frontal NN B-Biological_structure
right RB I-Biological_structure
paramedian JJ I-Biological_structure
lesion NN B-Sign_symptom
( ( O
Figure NNP O
1A CD O
) ) O
, , O
cerebral JJ B-Biological_structure
MRI NNP B-Diagnostic_procedure
( ( O
Figure NNP O
1 CD O
B NNP O
- : O
F NN O
) ) O
showed VBD O
a DT O
small JJ B-Detailed_description
right NN B-Detailed_description
parenchymal NN I-Detailed_description
homogeneous JJ B-Detailed_description
lesion NN B-Sign_symptom
16 CD B-Volume
/ NN I-Volume
22 CD I-Volume
/ NN I-Volume
15 CD I-Volume
mm NN I-Volume
, , O
well RB B-Detailed_description
delimited VBN I-Detailed_description
, , O
involving VBG O
gyrus NN B-Biological_structure
cinguli NN I-Biological_structure
, , O
without IN O
perilesional JJ B-Detailed_description
edema NN B-Sign_symptom
and CC O
mass NN B-Sign_symptom
effect NN I-Sign_symptom
, , O
hyperintense VB B-Detailed_description
both DT I-Detailed_description
on IN I-Detailed_description
T1 NNP I-Detailed_description
and CC I-Detailed_description
T2 NNP I-Detailed_description
MR NNP I-Detailed_description
sequences NNS I-Detailed_description
, , O
non SYM B-Detailed_description
- : I-Detailed_description
enhancing NN I-Detailed_description
after IN I-Detailed_description
Gadolinium NNP I-Detailed_description
. . O

The DT O
cerebral JJ B-Biological_structure
lesion NN B-Sign_symptom
was VBD O
also RB O
documented VBN O
on IN O
EEG NNP B-Diagnostic_procedure
and CC O
video SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
EEG JJ I-Diagnostic_procedure
recordings NNS O
: : O
3 CD B-Lab_value
seizures NNS B-Sign_symptom
with IN O
medio JJ B-Detailed_description
- : I-Detailed_description
frontal JJ I-Detailed_description
origin NN I-Detailed_description
and CC O
rare JJ B-Detailed_description
interictal JJ I-Detailed_description
epileptiform NN I-Detailed_description
elements NNS I-Detailed_description
were VBD O
recorded VBN O
( ( O
Figure NNP O
1I CD O
) ) O

Using VBG O
an DT O
interhemispheric JJ B-Biological_structure
microsurgical JJ B-Therapeutic_procedure
approach NN I-Therapeutic_procedure
, , O
above IN B-Biological_structure
the DT I-Biological_structure
corpus NN I-Biological_structure
callosum NN I-Biological_structure
and CC O
the DT O
right JJ B-Biological_structure
pericallosal NN I-Biological_structure
artery RB I-Biological_structure
, , O
at IN O
the DT O
level NN O
of IN O
gyrus NN B-Biological_structure
cinguli NN I-Biological_structure
, , O
a DT O
yellow JJ B-Color
- : I-Color
gray NN I-Color
, , O
infiltrative JJ B-Detailed_description
tumour NN B-Sign_symptom
, , O
having VBG O
a DT O
moderate JJ B-Severity
vascularisation NN B-Detailed_description
had VBD O
been VBN O
identified VBN O
and CC O
totally RB O
removed VBN B-Therapeutic_procedure
. . O

The DT O
anatomo NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
pathological JJ I-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
revealed VBD O
a DT O
grade NN B-Lab_value
Ⅱ NN I-Lab_value
astrocytoma NN B-Disease_disorder
. . O

The DT O
patient NN O
recovered VBD B-Sign_symptom
very RB O
well RB O
, , O
without IN O
deficits NNS B-Sign_symptom
, , O
no DT O
gelastic JJ B-Disease_disorder
seizures NNS I-Disease_disorder
or CC O
epileptic JJ B-Sign_symptom
manifestations NNS I-Sign_symptom
; : O
three CD O
months NNS O
after IN O
operation NN O
he PRP O
is VBZ O
still RB O
free JJ O
of IN O
seizures NNS B-Sign_symptom
. . O

A DT O
control NN O
postop NN O
CT NNP B-Diagnostic_procedure
revealed VBD O
no DT O
tumor NN B-Sign_symptom
( ( O
1 CD O
G NNP O
, , O
H NNP O
) ) O

-DOCSTART- NN -X-

A DT O
58 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
cotton NN B-Occupation
farmer NN I-Occupation
was VBD O
presented VBN O
to TO O
the DT O
West NNP B-Nonbiological_location
China NNP I-Nonbiological_location
Hospital NNP I-Nonbiological_location
of IN I-Nonbiological_location
Sichuan NNP I-Nonbiological_location
University NNP I-Nonbiological_location
because IN O
of IN O
an DT O
over IN B-Duration
1 CD I-Duration
- : I-Duration
month NN I-Duration
history NN O
of IN O
recurrent NN B-Detailed_description
fever NN B-Sign_symptom
( ( O
between IN B-Lab_value
38 CD I-Lab_value
and CC I-Lab_value
40 CD I-Lab_value
°C NN I-Lab_value
) ) O
, , O
productive JJ B-Detailed_description
cough NN B-Sign_symptom
, , O
and CC O
dyspnea NN B-Sign_symptom
. . O

Prior RB O
to TO O
admission NN O
, , O
he PRP O
was VBD O
diagnosed VBN O
of IN O
pneumonia NN B-Disease_disorder
and CC O
treated VBN O
with IN O
latamoxef NN B-Medication
, , O
ofloxacin NN B-Medication
, , O
vancomycin NN B-Medication
, , O
and CC O
voriconazole NN B-Medication
at IN O
local JJ B-Nonbiological_location
hospital NN I-Nonbiological_location
. . O

However RB O
, , O
no DT O
remission NN B-Sign_symptom
of IN I-Sign_symptom
symptoms NNS I-Sign_symptom
was VBD O
observed VBN O
. . O

Moreover RB O
, , O
he PRP O
was VBD O
a DT O
hepatitis NN O
B NNP O
virus NN O
carrier NN O
with IN O
a DT O
10 CD O
pack NN O
- : O
years NNS O
smoking VBG O
history NN O
. . O

However RB O
, , O
no DT O
history NN O
of IN O
diabetes NNS O
mellitus NNS O
, , O
tuberculosis NN O
, , O
and CC O
use NN O
of IN O
glucocorticoids NNS O
in IN O
the DT O
past NN O
were VBD O
informed VBN O
. . O

On IN O
admission NN O
, , O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
, , O
145 CD B-Lab_value
/ NN I-Lab_value
95 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
; : O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
, , O
120 CD B-Lab_value
per IN I-Lab_value
minute NN I-Lab_value
; : O
respiratory NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
, , O
30 CD B-Lab_value
per IN I-Lab_value
minute NN I-Lab_value
; : O
and CC O
temperature NN B-Diagnostic_procedure
, , O
39 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
°C NN I-Lab_value
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
diminished JJ B-Sign_symptom
breath NN I-Sign_symptom
sounds NNS I-Sign_symptom
, , O
but CC O
no DT O
rales NNS B-Sign_symptom
were VBD O
heard VBN O
, , O
and CC O
evaluation NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
other JJ I-Diagnostic_procedure
systems NNS I-Diagnostic_procedure
was VBD O
unremarkable JJ B-Lab_value
except IN O
moderate JJ B-Severity
edema NN B-Sign_symptom
of IN O
lower JJR B-Biological_structure
limbs NN I-Biological_structure
. . O

Arterial JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
gases NNS I-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
showed VBD O
pH JJ B-Diagnostic_procedure
7 CD B-Lab_value
. . I-Lab_value
361 CD I-Lab_value
, , O
PCO2 NNP B-Diagnostic_procedure
53 CD B-Lab_value
. . I-Lab_value
5 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
, , O
and CC O
PO2 NNP B-Diagnostic_procedure
62 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
mm JJ I-Lab_value
Hg NNP I-Lab_value
. . O

Laboratory NNP O
data NNS O
( ( O
Table NNP O
( ( O
Table1 NNP O
) ) O
1 CD O
) ) O
revealed VBD O
leukocytosis NN B-Diagnostic_procedure
of IN O
49,500 CD B-Lab_value
/ NNS I-Lab_value
mm3 NN I-Lab_value
with IN O
97 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
% NN I-Lab_value
neutrophils NNS I-Lab_value
, , O
and CC O
elevated VBD O
procalcitonin NN B-Diagnostic_procedure
of IN O
5 CD B-Lab_value
. . I-Lab_value
16 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
. . O

Chest NNP B-Biological_structure
computed VBD B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
, , O
presence NN O
of IN O
nodules NNS B-Sign_symptom
, , O
masses NNS B-Sign_symptom
, , O
patchy JJ B-Sign_symptom
consolidations NNS I-Sign_symptom
, , O
and CC O
bilateral JJ B-Sign_symptom
pleural JJ I-Sign_symptom
effusion NN I-Sign_symptom
, , O
is VBZ O
noted VBN O
( ( O
Fig NNP O
. . O
1A CD O
) ) O
. . O

Meanwhile RB O
, , O
it PRP O
was VBD O
soon RB O
alerted VBN O
in IN O
sputum NN B-Diagnostic_procedure
smear NN I-Diagnostic_procedure
with IN O
presence NN O
of IN O
filamentous JJ B-Detailed_description
, , O
gram JJ B-Detailed_description
- : I-Detailed_description
positive JJ I-Detailed_description
, , O
weakly JJ B-Detailed_description
acid SYM I-Detailed_description
- : I-Detailed_description
fast NN I-Detailed_description
, , O
and CC O
beaded VBD B-Detailed_description
bacilli NN B-Sign_symptom
with IN O
possible JJ O
diagnosis NN O
of IN O
Nocardia NNP B-Disease_disorder
infection NN I-Disease_disorder
( ( O
Fig NNP O
. . O
1B CD O
, , O
C NNP O
) ) O
. . O

Trimethoprim NNP B-Medication
- : I-Medication
sulfamethoxazole NN I-Medication
( ( O
3 CD B-Dosage
pills NNS I-Dosage
per IN I-Dosage
6 CD I-Dosage
hours NNS I-Dosage
) ) O
with IN O
noninvasive JJ B-Detailed_description
ventilation NN B-Therapeutic_procedure
was VBD O
promptly RB O
administered VBN O
. . O

Sputum JJ B-Diagnostic_procedure
culture NN I-Diagnostic_procedure
showed VBD O
growth NN B-Lab_value
of IN I-Lab_value
numerous JJ I-Lab_value
bacteria NNS I-Lab_value
that WDT O
were VBD O
precisely RB O
determined VBN O
to TO O
be VB O
N NNP B-Sign_symptom
otitidiscaviarum NN I-Sign_symptom
by IN O
the DT O
method NN O
of IN O
mass NN B-Diagnostic_procedure
spectroscopy NN I-Diagnostic_procedure
on IN O
day NN O
6 CD O
after IN O
admission NN O
( ( O
Fig NNP O
. . O
1D CD O
) ) O
. . O

Antibiotics NNS B-Medication
were VBD O
thus RB O
modified VBN O
to TO O
amikacin VB B-Medication
and CC O
imipenem VB B-Medication
in IN O
addition NN O
to TO O
trimethoprim VB B-Medication
- : I-Medication
sulfamethoxazole NN I-Medication
in IN O
accordance NN O
with IN O
the DT O
sensitivity NN O
test NN O
. . O

However RB O
, , O
the DT O
patient NN O
was VBD O
not RB O
improved VBN B-Sign_symptom
as IN O
expected VBN O
and CC O
eventually RB O
died VBD O
from IN O
severe JJ B-Severity
respiratory NN B-Sign_symptom
insufficiency NN I-Sign_symptom
on IN O
the DT O
13th JJ O
hospital NN O
day NN O
. . O

-DOCSTART- NN -X-

An DT O
18 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
male NN O
was VBD O
diagnosed VBN O
with IN O
attention NN B-Disease_disorder
- : I-Disease_disorder
deficit NN I-Disease_disorder
hyperactivity NN I-Disease_disorder
disorder NN I-Disease_disorder
( ( O
ADHD NNP B-Disease_disorder
) ) O
in IN O
2005 CD O
. . O

He PRP O
was VBD O
overweight VBN B-Sign_symptom
with IN O
a DT O
body NN B-Diagnostic_procedure
mass NN I-Diagnostic_procedure
index NN I-Diagnostic_procedure
( ( O
BMI NNP B-Diagnostic_procedure
) ) O
of IN O
40 CD B-Lab_value
. . O

He PRP O
was VBD O
started VBN O
on IN O
quetiapine NN B-Medication
fumarate NN I-Medication
( ( B-Medication
Seroquel NNP I-Medication
® NNP I-Medication
) ) I-Medication
900 CD B-Dosage
mg JJ I-Dosage
daily RB I-Dosage
in IN O
April NNP O
2005 CD O
and CC O
methylphenidate VB B-Medication
( ( B-Medication
Concerta NNP I-Medication
® NNP I-Medication
) ) I-Medication
54 CD B-Dosage
mg JJ I-Dosage
daily RB I-Dosage
in IN O
September NNP O
2005 CD O
. . O

In IN O
the DT O
beginning NN O
of IN O
August NNP O
2006 CD O
he PRP O
was VBD O
admitted VBN O
to TO O
his PRP$ O
local JJ B-Nonbiological_location
hospital NN I-Nonbiological_location
with IN O
severe JJ B-Severity
dyspnoea NN B-Sign_symptom
, , O
tachypnea NN B-Sign_symptom
, , O
tachycardia NN B-Sign_symptom
, , O
and CC O
cyanosis NN B-Sign_symptom
. . O

On IN O
admission NN O
the DT O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
120 CD B-Lab_value
/ JJ I-Lab_value
80 CD I-Lab_value
mmHg NN I-Lab_value
, , O
and CC O
the DT O
arterial JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
gas NN I-Diagnostic_procedure
revealed VBD O
a DT O
pH NN B-Diagnostic_procedure
of IN O
7 CD B-Lab_value
. . I-Lab_value
45 CD I-Lab_value
, , O
pCO2 NN B-Diagnostic_procedure
of IN O
3 CD B-Lab_value
. . I-Lab_value
55 CD I-Lab_value
kPa NN I-Lab_value
, , O
paO2 NN B-Diagnostic_procedure
of IN O
7 CD B-Lab_value
. . I-Lab_value
76 CD I-Lab_value
kPa NN I-Lab_value
, , O
and CC O
BE NNP B-Diagnostic_procedure
of IN O
− NNP B-Lab_value
5 CD I-Lab_value
. . I-Lab_value
1 CD I-Lab_value
mmol JJ I-Lab_value
/ NNP I-Lab_value
l NN I-Lab_value
. . O

C NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
reactive JJ I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
was VBD O
not RB B-Lab_value
elevated VBN I-Lab_value
. . O

The DT O
chest JJS B-Biological_structure
X SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
showed VBD O
an DT O
enlarged JJ B-Sign_symptom
heart NN I-Sign_symptom
. . O

He PRP O
developed VBD O
hemoptysis NN B-Sign_symptom
and CC O
was VBD O
treated VBN O
with IN O
unfractionated JJ B-Detailed_description
heparin NN B-Medication
in IN O
suspicion NN O
of IN O
pulmonary JJ B-Biological_structure
embolism NN B-Sign_symptom
. . O

He PRP O
subsequently RB O
developed VBD O
cardiogenic JJ B-Disease_disorder
shock NN I-Disease_disorder
and CC O
was VBD O
treated VBN O
with IN O
vasoactive JJ B-Medication
drugs NNS I-Medication
. . O

In IN O
spite NN O
of IN O
the DT O
treatment NN O
he PRP O
became VBD O
oliguric JJ B-Sign_symptom
and CC O
his PRP$ O
liver NN B-Diagnostic_procedure
enzymes NNS I-Diagnostic_procedure
were VBD O
rising VBG B-Lab_value
. . O

He PRP O
was VBD O
referred VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
for IN O
further JJ O
treatment NN O
. . O

On IN O
admission NN O
the DT O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
90 CD B-Lab_value
/ JJ I-Lab_value
60 CD I-Lab_value
mmHg NN I-Lab_value
, , O
despite IN O
infusion NN O
with IN O
noradrenaline NN B-Medication
. . O

His PRP$ O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
was VBD O
130 CD B-Lab_value
/ NNP I-Lab_value
minute NN I-Lab_value
and CC O
his PRP$ O
temperature NN B-Diagnostic_procedure
was VBD O
38 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
°C NN I-Lab_value
. . O

A DT O
thoracic NN B-Biological_structure
computed VBN B-Diagnostic_procedure
tomography JJ I-Diagnostic_procedure
scan NN I-Diagnostic_procedure
did VBD B-Sign_symptom
not RB I-Sign_symptom
show VB I-Sign_symptom
pulmonary JJ I-Sign_symptom
embolism NN I-Sign_symptom
. . O

Echocardiography NNP B-Diagnostic_procedure
revealed VBD O
biventricular JJ B-Sign_symptom
failure NN I-Sign_symptom
and CC O
left VBD B-Diagnostic_procedure
ventricular JJ I-Diagnostic_procedure
end NN I-Diagnostic_procedure
diastolic NN I-Diagnostic_procedure
diameter NN I-Diagnostic_procedure
was VBD O
7 CD B-Distance
cm NN I-Distance
. . O

The DT O
left JJ B-Biological_structure
ventricle NN I-Biological_structure
was VBD O
severely RB B-Severity
hypokinetic JJ B-Lab_value
with IN O
an DT O
ejection NN B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
( ( O
EF NNP B-Diagnostic_procedure
) ) O
of IN O
20 CD B-Lab_value
% NN I-Lab_value
- : I-Lab_value
25 CD I-Lab_value
% NN I-Lab_value
. . O

The DT O
left NN B-Diagnostic_procedure
ventricular JJ I-Diagnostic_procedure
end NN I-Diagnostic_procedure
diastolic JJ I-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
markedly RB O
elevated VBN B-Lab_value
, , O
and CC O
there RB O
was VBD O
a DT O
moderate JJ B-Lab_value
mitral JJ B-Sign_symptom
regurgitation NN I-Sign_symptom
. . O

Intermittent JJ B-Detailed_description
hemodialysis NN B-Therapeutic_procedure
was VBD O
initiated VBN O
. . O

His PRP$ O
liver NN B-Diagnostic_procedure
function NN I-Diagnostic_procedure
improved VBD B-Lab_value
slightly RB B-Severity
, , O
but CC O
despite IN O
dialysis NN O
the DT O
renal JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
deteriorated VBN B-Lab_value
with IN O
increasing VBG B-Lab_value
creatinine NN B-Diagnostic_procedure
values NNS I-Diagnostic_procedure
. . O

After IN O
three CD O
days NNS O
there RB O
was VBD O
a DT O
further JJ O
worsening NN B-Lab_value
of IN O
the DT O
left NN B-Diagnostic_procedure
ventricular JJ I-Diagnostic_procedure
systolic JJ I-Diagnostic_procedure
function NN I-Diagnostic_procedure
with IN O
an DT O
ejection NN B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
of IN O
10 CD B-Lab_value
% NN I-Lab_value
- : I-Lab_value
12 CD I-Lab_value
% NN I-Lab_value
and CC O
marked VBD O
pulmonary JJ B-Sign_symptom
hypertension NN I-Sign_symptom
with IN O
systolic JJ B-Diagnostic_procedure
pulmonary JJ I-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
estimated VBN O
to TO O
30 CD B-Lab_value
mmHg NNS I-Lab_value
. . O

The DT O
clinical JJ O
picture NN O
resembled VBD O
dilated VBN B-Detailed_description
cardiomyopathy JJ B-Disease_disorder
with IN O
low JJ B-Sign_symptom
output NN I-Sign_symptom
failure NN I-Sign_symptom
causing VBG O
renal JJ B-Biological_structure
and CC O
liver JJ B-Biological_structure
failure NN B-Sign_symptom
. . O

We PRP O
suspected VBD O
drug NN B-Detailed_description
- : I-Detailed_description
induced VBN I-Detailed_description
cardiomyopathy NN O
and CC O
methylphenidate NN B-Medication
and CC O
quetiapine JJ B-Medication
fumarate NN I-Medication
were VBD O
discontinued VBN O
. . O

Screening VBG B-Diagnostic_procedure
for IN I-Diagnostic_procedure
infectious JJ I-Diagnostic_procedure
pathogens NNS I-Diagnostic_procedure
, , O
immunological JJ B-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
, , O
and CC O
iron NN B-Diagnostic_procedure
or CC O
amyloid JJ B-Diagnostic_procedure
deposition NN I-Diagnostic_procedure
were VBD O
all DT O
negative JJ B-Lab_value
. . O

After IN O
three CD O
days NNS O
he PRP O
was VBD O
transferred VBN O
to TO O
the DT O
National NNP B-Nonbiological_location
Hospital NNP I-Nonbiological_location
( ( I-Nonbiological_location
Rikshospitalet NNP I-Nonbiological_location
, , I-Nonbiological_location
Oslo NNP I-Nonbiological_location
) ) I-Nonbiological_location
with IN O
ongoing VBG O
noradrenaline NN B-Medication
and CC O
dobutamine JJ B-Medication
infusions NNS O
. . O

Shortly RB O
after IN O
admission NN O
an DT O
intraaortic JJ B-Therapeutic_procedure
balloon NN I-Therapeutic_procedure
pump NN I-Therapeutic_procedure
( ( O
IABP NNP B-Therapeutic_procedure
) ) O
was VBD O
inserted VBN O
and CC O
noradrenaline NN O
was VBD O
replaced VBN O
by IN O
nitroprusside NN B-Medication
. . O

Coronary JJ B-Diagnostic_procedure
angiography NN I-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
. . O

Endomyocardial JJ B-Biological_structure
biopsy NN B-Diagnostic_procedure
from IN O
the DT O
right JJ B-Biological_structure
ventricle NN I-Biological_structure
did VBD O
not RB O
reveal VB O
any DT O
distinct JJ O
myocardial JJ B-Disease_disorder
pathology NN I-Disease_disorder
. . O

On IN O
treatment NN O
with IN O
IABP NNP O
, , O
nitroprusside RB O
, , O
and CC O
dialysis NN B-Therapeutic_procedure
, , O
the DT O
clinical JJ B-Diagnostic_procedure
situation NN I-Diagnostic_procedure
gradually RB O
improved VBN B-Lab_value
and CC O
the DT O
liver NN B-Diagnostic_procedure
function NN I-Diagnostic_procedure
returned VBD O
to TO O
normal JJ B-Lab_value
. . O

His PRP$ O
renal JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
also RB O
improved VBN B-Lab_value
with IN O
increasing VBG O
diuresis NN B-Sign_symptom
and CC O
creatinine NN B-Diagnostic_procedure
fell VBD O
from IN O
798 CD B-Lab_value
to TO O
98 CD B-Lab_value
μmol NNS I-Lab_value
/ JJ I-Lab_value
l NN I-Lab_value
. . O

His PRP$ O
EF NN B-Diagnostic_procedure
was VBD O
still RB O
markedly RB O
reduced VBN B-Lab_value
( ( O
15 CD B-Lab_value
% NN I-Lab_value
) ) O
. . O

Because IN O
of IN O
behavioral JJ B-Sign_symptom
problems NNS I-Sign_symptom
and CC O
adipose JJ B-Sign_symptom
stature NN I-Sign_symptom
, , O
he PRP O
was VBD O
denied VBN O
a DT O
heart NN B-Therapeutic_procedure
transplant NN I-Therapeutic_procedure
. . O

He PRP O
was VBD O
treated VBN O
with IN O
IABP NNP O
for IN O
26 CD B-Duration
days NNS I-Duration
, , O
and CC O
after IN B-Duration
28 CD I-Duration
days NNS I-Duration
he PRP O
was VBD O
transferred VBN O
back RB O
to TO O
our PRP$ B-Nonbiological_location
hospital NN I-Nonbiological_location
. . O

At IN O
that DT O
time NN O
his PRP$ O
liver NN B-Diagnostic_procedure
and CC I-Diagnostic_procedure
renal JJ I-Diagnostic_procedure
functions NNS I-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

He PRP O
was VBD O
treated VBN O
with IN O
an DT O
angiotensin NN B-Medication
- : I-Medication
converting VBG I-Medication
enzyme NN I-Medication
( ( I-Medication
ACE NNP I-Medication
) ) I-Medication
- : I-Medication
inhibitor NN I-Medication
, , O
a DT O
beta NN B-Medication
- : I-Medication
blocker NN I-Medication
, , O
and CC O
diuretics NNS B-Medication
. . O

During IN O
the DT O
following JJ O
two CD B-Duration
weeks NNS I-Duration
his PRP$ O
clinical JJ B-Diagnostic_procedure
status NN I-Diagnostic_procedure
improved VBD B-Lab_value
and CC O
he PRP O
was VBD O
subsequently RB O
discharged VBN O
to TO O
his PRP$ B-Nonbiological_location
home NN I-Nonbiological_location
. . O

The DT O
echocardiography NN B-Diagnostic_procedure
still RB O
showed VBD O
markedly RB O
dilated VBN B-Lab_value
left JJ B-Biological_structure
ventricle NN I-Biological_structure
with IN O
EF NNP B-Diagnostic_procedure
of IN O
20 CD B-Lab_value
% NN I-Lab_value
. . O

In IN O
March NNP O
2007 CD O
, , O
his PRP$ O
clinical JJ B-Diagnostic_procedure
status NN I-Diagnostic_procedure
was VBD O
improved VBN B-Lab_value
and CC O
he PRP O
was VBD O
in IN O
function NN B-Diagnostic_procedure
class NN I-Diagnostic_procedure
II NNP B-Lab_value
( ( O
New NNP B-Detailed_description
York NNP I-Detailed_description
Heart NNP I-Detailed_description
Association NNP I-Detailed_description
) ) O
with IN O
an DT O
EF NNP B-Diagnostic_procedure
estimated VBN O
by IN O
echocardiography NN B-Diagnostic_procedure
to TO O
30 CD B-Lab_value
% NN I-Lab_value
- : I-Lab_value
35 CD I-Lab_value
% NN I-Lab_value
. . O

-DOCSTART- NN -X-

A DT O
25 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
female JJ O
patient NN O
had VBD O
noticed VBN O
left VBN B-Detailed_description
- : I-Detailed_description
sided VBN I-Detailed_description
visual JJ B-Disease_disorder
loss NN I-Disease_disorder
and CC O
amenorrhea JJ B-Disease_disorder
2 CD O
years NNS O
prior RB O
to TO O
being VBG O
seen VBN O
, , O
with IN O
right JJ B-Detailed_description
hemiparesis NN B-Disease_disorder
developing VBG O
6 CD O
months NNS O
beforehand RB O
. . O

Aggravated VBN B-Severity
symptoms NNS B-Sign_symptom
( ( O
drooping VBG B-Sign_symptom
at IN O
corner NN B-Biological_structure
of IN I-Biological_structure
right JJ I-Biological_structure
lip NN I-Biological_structure
and CC O
bilateral JJ B-Detailed_description
temporal JJ B-Detailed_description
hemianopia NN B-Disease_disorder
) ) O
finally RB O
prompted VBN O
hospitalization NN O
. . O

At IN O
that DT O
time NN O
, , O
a DT O
massive JJ B-Severity
( ( O
> JJ B-Distance
5 CD I-Distance
cm NN I-Distance
) ) O
tumor NN B-Sign_symptom
of IN O
intra JJ B-Biological_structure
- : I-Biological_structure
and CC I-Biological_structure
suprasellar JJ I-Biological_structure
location NN I-Biological_structure
, , O
excluding VBG B-Detailed_description
mesencephalon NN I-Detailed_description
backward NN I-Detailed_description
, , O
was VBD O
seen VBN O
on IN O
computerized JJ B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
of IN O
the DT O
head NN B-Biological_structure
( ( O
Fig NNP O
. . O
1a CD O
) ) O
. . O

Further RB O
testing VBG O
revealed VBD O
an DT O
exceedingly RB B-Lab_value
high JJ I-Lab_value
- : O
serum JJ B-Biological_structure
level NN O
of IN O
prolactin NN B-Diagnostic_procedure
( ( O
PRL NNP B-Diagnostic_procedure
) ) O
( ( O
4408 CD B-Lab_value
ng NN I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
) ) O
, , O
whereas JJ O
levels NNS O
of IN O
all DT O
other JJ B-Diagnostic_procedure
pituitary JJ I-Diagnostic_procedure
hormones NNS I-Diagnostic_procedure
were VBD O
within IN B-Lab_value
reference NN I-Lab_value
ranges NNS I-Lab_value
( ( B-Diagnostic_procedure
growth NN I-Diagnostic_procedure
hormone NN I-Diagnostic_procedure
( ( O
GH NNP B-Diagnostic_procedure
) ) O
, , O
0 CD B-Lab_value
. . I-Lab_value
50 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
; : O
luteinizing VBG B-Diagnostic_procedure
hormone NN I-Diagnostic_procedure
( ( O
LH NNP B-Diagnostic_procedure
) ) O
, , O
2 CD B-Lab_value
. . I-Lab_value
60 CD I-Lab_value
mIU JJ I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
; : O
follicle CC B-Diagnostic_procedure
- : I-Diagnostic_procedure
stimulating VBG I-Diagnostic_procedure
hormone NN I-Diagnostic_procedure
( ( O
FSH NNP B-Diagnostic_procedure
) ) O
, , O
4 CD B-Lab_value
. . I-Lab_value
57 CD I-Lab_value
mIU JJ I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
; : O
adrenocorticotropic CC B-Diagnostic_procedure
hormone NN I-Diagnostic_procedure
( ( O
ACTH NNP B-Diagnostic_procedure
) ) O
, , O
37 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
pg JJ I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
; : O
thyroid CC B-Diagnostic_procedure
- : I-Diagnostic_procedure
stimulating VBG I-Diagnostic_procedure
hormone NN I-Diagnostic_procedure
( ( O
TSH NNP B-Diagnostic_procedure
) ) O
, , O
2 CD B-Lab_value
. . I-Lab_value
68 CD I-Lab_value
μIU JJ I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
) ) O
. . O

T1 NNP B-Detailed_description
- : I-Detailed_description
weighted VBD I-Detailed_description
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
( ( O
MR NNP B-Diagnostic_procedure
) ) O
imaging VBG O
with IN O
contrast NN B-Detailed_description
( ( O
gadolinium NN B-Detailed_description
) ) O
showed VBD O
homogeneous JJ B-Detailed_description
tumor NN B-Sign_symptom
enhancement NN B-Detailed_description
, , O
but CC O
adjacent JJ B-Biological_structure
tissue NN I-Biological_structure
was VBD O
not RB O
edematous JJ B-Sign_symptom
in IN O
T2 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
weighted JJ I-Diagnostic_procedure
views NNS I-Diagnostic_procedure
. . O

The DT O
mass NN B-Sign_symptom
did VBD O
not RB O
regress VB B-Sign_symptom
, , O
despite IN O
a DT O
4 CD B-Duration
- : I-Duration
week NN I-Duration
course NN O
of IN O
the DT O
dopamine NN B-Medication
analog NN I-Medication
, , O
cabergoline NN B-Medication
( ( O
1 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
week NN I-Dosage
) ) O
, , O
and CC O
serum JJ B-Biological_structure
PRL NNP B-Diagnostic_procedure
level NN O
( ( O
2207 CD B-Lab_value
ng NN I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
) ) O
remained VBD O
elevated JJ B-Lab_value
. . O

Relative JJ O
to TO O
status NN O
at IN O
admission NN O
, , O
the DT O
right JJ B-Biological_structure
lateral JJ I-Biological_structure
ventricle NN I-Biological_structure
also RB O
had VBD O
enlarged VBN B-Sign_symptom
somewhat RB B-Severity
, , O
due JJ O
to TO O
obstruction NN B-Sign_symptom
at IN O
foramen NNS B-Biological_structure
of IN I-Biological_structure
Monro NNP I-Biological_structure
( ( O
Fig NNP O
. . O
1b CD O
) ) O
. . O

In IN O
light NN O
of IN O
this DT O
intransigence NN O
, , O
surgical JJ B-Detailed_description
debulking NN B-Therapeutic_procedure
of IN O
tumor NN O
was VBD O
elected VBN O
first RB O
, , O
through IN O
craniotomy NN B-Therapeutic_procedure
and CC O
then RB O
via IN O
transsphenoidal JJ B-Therapeutic_procedure
approach NN I-Therapeutic_procedure
. . O

The DT O
hardened VBN B-Texture
elastic JJ I-Texture
quality NN O
of IN O
the DT O
tumor NN B-Sign_symptom
and CC O
its PRP$ O
strong JJ B-Severity
attachments NNS B-Sign_symptom
to TO O
neighboring VBG B-Biological_structure
structures NNS I-Biological_structure
prevented VBD O
complete JJ B-Therapeutic_procedure
removal NN I-Therapeutic_procedure
, , O
but CC O
related JJ O
mass NN B-Sign_symptom
effect NN I-Sign_symptom
was VBD O
significantly RB O
reduced VBN O
and CC O
serum JJ B-Biological_structure
PRL NNP B-Diagnostic_procedure
level NN O
declined VBD B-Lab_value
( ( O
to TO O
250 CD B-Lab_value
ng NNS I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
) ) O
in IN O
steps NNS O
at IN O
each DT O
procedural JJ O
stage NN O
. . O

But CC O
the DT O
normalization NN B-Lab_value
of IN O
PRL NNP B-Diagnostic_procedure
level NN O
had VBD O
not RB O
been VBN O
achieved VBN O
with IN O
the DT O
administration NN O
of IN O
cabergoline NN B-Medication
increased VBN O
up RB O
to TO O
0 CD B-Dosage
. . I-Dosage
5 CD I-Dosage
mg JJ I-Dosage
/ NNP I-Dosage
day NN I-Dosage
. . O

The DT O
residual JJ O
tumor NN O
showed VBD O
no DT O
evidence NN O
of IN O
regrowth NN B-Sign_symptom
or CC O
distant JJ B-Detailed_description
metastasis NN B-Sign_symptom
1 CD O
year NN O
after IN O
surgery NN O
. . O

Histopathologically RB B-Diagnostic_procedure
, , O
hematoxylin NN B-Diagnostic_procedure
and CC I-Diagnostic_procedure
eosin NN I-Diagnostic_procedure
( ( O
H&E NNP B-Diagnostic_procedure
) ) O
- : O
stained VBN O
sections NNS O
of IN O
specimens NNS B-Biological_structure
from IN O
the DT O
first JJ O
and CC O
second JJ O
surgical JJ O
procedures NNS O
similarly RB O
were VBD O
composed VBN O
of IN O
polygonal JJ B-Detailed_description
and CC O
spindle JJ B-Sign_symptom
cells NNS I-Sign_symptom
with IN O
round NN B-Shape
, , O
oval NN B-Shape
, , O
or CC O
elongated VBN B-Shape
nuclei NNS B-Diagnostic_procedure
and CC O
eosinophilic JJ B-Lab_value
cytoplasm NN B-Diagnostic_procedure
( ( O
Fig NNP O
. . O
2a CD O
- : O
c NN O
) ) O
. . O

The DT O
cells NNS O
formed VBD O
irregular JJ B-Detailed_description
nests NNS I-Detailed_description
or CC O
short JJ B-Detailed_description
fascicles NNS I-Detailed_description
, , O
accompanied VBN O
by IN O
frequent JJ B-Detailed_description
hyaline NN I-Detailed_description
changes NNS I-Detailed_description
in IN I-Detailed_description
vessel NN I-Detailed_description
walls NNS I-Detailed_description
and CC I-Detailed_description
vacuolation NN I-Detailed_description
( ( O
Fig NNP O
. . O
2d CD O
) ) O
. . O

Some DT O
nuclear JJ B-Sign_symptom
pleomorphism NN I-Sign_symptom
was VBD O
prominent JJ O
; : O
on IN O
the DT O
other JJ O
hand NN O
, , O
neither CC O
a DT O
high JJ B-Sign_symptom
mitotic JJ I-Sign_symptom
rate NN I-Sign_symptom
nor CC O
necrosis NN B-Sign_symptom
was VBD O
evident JJ O
( ( O
Fig NNP O
. . O
2b CD O
, , O
c NN O
) ) O
. . O

Conspicuous JJ O
fibrous JJ B-Sign_symptom
change NN I-Sign_symptom
of IN O
tumor NN B-Biological_structure
stroma NN I-Biological_structure
was VBD O
noted VBN O
focally RB O
as RB O
well RB O
( ( O
Fig NNP O
. . O
3a CD O
) ) O
. . O

The DT O
chromophobic JJ B-Lab_value
nature NN O
of IN O
tumor NN B-Biological_structure
cells NNS I-Biological_structure
was VBD O
confirmed VBN O
by IN O
Pearse NNP B-Diagnostic_procedure
` `` I-Diagnostic_procedure
s RB I-Diagnostic_procedure
Periodic NNP I-Diagnostic_procedure
Acid NNP I-Diagnostic_procedure
Schiff NNP I-Diagnostic_procedure
( ( O
PAS NNP B-Diagnostic_procedure
) ) O
stain NN O
( ( O
Fig NNP O
. . O
3b CD O
) ) O
. . O

Immunostains NNS B-Diagnostic_procedure
showed VBD O
strong JJ O
diffuse NN O
positivity NN B-Lab_value
for IN O
PRL NNP B-Diagnostic_procedure
( ( O
Fig NNP O
. . O
3c CD O
) ) O
, , O
chromogranin SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
A NN I-Diagnostic_procedure
, , O
and CC O
synaptophysin NN B-Diagnostic_procedure
. . O

No DT B-Lab_value
other JJ B-Diagnostic_procedure
hormones NNS I-Diagnostic_procedure
( ( O
GH NNP B-Diagnostic_procedure
, , O
TSH NNP B-Diagnostic_procedure
, , O
ACTH NNP B-Diagnostic_procedure
, , O
LH NNP B-Diagnostic_procedure
, , O
FSH NNP B-Diagnostic_procedure
) ) O
were VBD O
expressed VBN O
by IN O
tumor NN O
cells NNS O
, , O
and CC O
the DT O
other JJ B-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
, , O
including VBG O
S NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
100 CD I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
3d CD O
) ) O
, , O
glial JJ B-Diagnostic_procedure
fibrillary JJ I-Diagnostic_procedure
acidic NN I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
( ( O
GFAP NNP B-Diagnostic_procedure
) ) O
, , O
epithelial JJ B-Diagnostic_procedure
membrane NN I-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
( ( O
EMA NNP B-Diagnostic_procedure
) ) O
, , O
cytokeratin JJ B-Diagnostic_procedure
AE1 NNP I-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
AE3 NNP I-Diagnostic_procedure
( ( O
CK NNP B-Diagnostic_procedure
AE1 NNP I-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
AE3 NNP I-Diagnostic_procedure
) ) O
, , O
vimentin FW B-Diagnostic_procedure
, , O
p53 NN B-Diagnostic_procedure
, , O
and CC O
bcl SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
2 CD I-Diagnostic_procedure
, , O
were VBD O
also RB O
negative JJ B-Lab_value
by IN O
immunostaining VBG O
. . O

Ki NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
67 CD I-Diagnostic_procedure
labeling VBG I-Diagnostic_procedure
index NN I-Diagnostic_procedure
was VBD O
approximately RB O
2 CD B-Lab_value
% NN I-Lab_value
. . O

A DT O
final JJ O
diagnosis NN O
of IN O
PRL NNP B-Detailed_description
- : I-Detailed_description
producing VBG I-Detailed_description
pituitary JJ B-Disease_disorder
adenoma NN I-Disease_disorder
was VBD O
reached VBN O
after IN O
considering VBG O
the DT O
immunohistochemical JJ O
profile NN O
, , O
suprasellar JJ O
location NN O
, , O
and CC O
prolactin JJ O
production NN O
of IN O
the DT O
tumor NN O
, , O
as RB O
well RB O
as IN O
the DT O
absence NN O
of IN O
metastatic JJ O
foci NN O
and CC O
invasion NN O
into IN O
surrounding VBG O
tissue NN O
. . O

-DOCSTART- NN -X-

A DT O
74 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
was VBD O
referred VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
in IN O
November NNP O
2000 CD O
because IN O
of IN O
liver JJ B-Sign_symptom
dysfunction NN I-Sign_symptom
detected VBD O
during IN O
a DT O
medical JJ O
checkup NN O
. . O

The DT O
patient NN O
had VBD O
been VBN O
diagnosed VBN O
with IN O
nephrotic JJ B-Disease_disorder
syndrome NN I-Disease_disorder
in IN O
1995 CD O
. . O

Laboratory NN B-Diagnostic_procedure
examinations NNS I-Diagnostic_procedure
showed VBD O
elevated JJ B-Lab_value
serum NN B-Diagnostic_procedure
hepatobiliary JJ I-Diagnostic_procedure
enzymes NNS I-Diagnostic_procedure
and CC O
IgM NNP B-Diagnostic_procedure
, , O
and CC O
the DT O
presence NN B-Lab_value
of IN O
antimitochondrial JJ B-Diagnostic_procedure
antibodies NNS I-Diagnostic_procedure
. . O

Serologic JJ B-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
for IN O
Hepatitis NNP B-Diagnostic_procedure
B NNP I-Diagnostic_procedure
and CC I-Diagnostic_procedure
C NNP I-Diagnostic_procedure
viruses NNS O
were VBD O
negative JJ B-Lab_value
. . O

Histopathologic NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
a DT O
liver NN B-Biological_structure
biopsy NN B-Diagnostic_procedure
specimen NNS I-Diagnostic_procedure
obtained VBN O
at IN O
laparoscopy NN B-Therapeutic_procedure
revealed VBD O
non JJ B-Detailed_description
- : I-Detailed_description
suppurative JJ I-Detailed_description
destructive JJ B-Detailed_description
cholangitis NN B-Disease_disorder
in IN O
the DT O
portal JJ B-Biological_structure
area NN I-Biological_structure
( ( O
Figure NNP O
1 CD O
) ) O
. . O

The DT O
diagnosis NN O
of IN O
PBC NNP B-Disease_disorder
( ( O
Scheuer NNP B-Disease_disorder
stage NN I-Disease_disorder
3 CD I-Disease_disorder
) ) O
was VBD O
confirmed VBN O
and CC O
ursodeoxycholic JJ B-Medication
acid NN I-Medication
, , O
900 CD B-Dosage
mg JJ I-Dosage
daily RB B-Frequency
, , O
was VBD O
started VBN O
. . O

In IN O
January NNP O
and CC O
June NNP O
2002 CD O
, , O
the DT O
patient JJ O
underwent JJ O
endoscopic NN B-Therapeutic_procedure
variceal NN I-Therapeutic_procedure
ligation NN I-Therapeutic_procedure
plus CC O
endoscopic JJ B-Therapeutic_procedure
injection NN I-Therapeutic_procedure
sclerotherapy NN I-Therapeutic_procedure
as RB O
well RB O
as IN O
argon NN B-Therapeutic_procedure
plasma NN I-Therapeutic_procedure
coagulation NN I-Therapeutic_procedure
for IN O
worsening VBG B-Severity
esophageal JJ B-Sign_symptom
varices NNS I-Sign_symptom
. . O

In IN O
September NNP O
2007 CD O
, , O
the DT O
patient NN O
was VBD O
admitted VBN O
for IN O
the DT O
treatment NN O
of IN O
recurrent JJ B-Severity
esophageal NN B-Sign_symptom
varices NNS I-Sign_symptom
. . O

The DT O
platelet NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
had VBD O
ranged VBN O
between IN O
52 CD B-Lab_value
× $ I-Lab_value
109 CD I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
and CC O
69 CD B-Lab_value
× NNS I-Lab_value
109 CD I-Lab_value
/ NNS I-Lab_value
L NNP I-Lab_value
for IN O
several JJ B-Duration
years NNS I-Duration
, , O
but CC O
it PRP O
was VBD O
noted VBN O
to TO O
decrease VB B-Lab_value
from IN O
61 CD B-Lab_value
× $ I-Lab_value
109 CD I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
in IN O
June NNP O
2007 CD O
to TO O
8 CD B-Lab_value
× NNS I-Lab_value
109 CD I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
just RB O
before IN O
admission NN O
. . O

Before IN O
the DT O
deterioration NN B-Detailed_description
of IN O
thrombocytopenia NN B-Sign_symptom
, , O
the DT O
patient NN O
had VBD O
no DT O
infectious JJ B-Disease_disorder
diseases NNS I-Disease_disorder
and CC O
received VBN O
no DT O
other JJ O
medication NN B-Medication
. . O

On IN O
admission NN O
, , O
the DT O
patient NN O
had VBD O
neither CC O
purpura JJ B-Sign_symptom
nor CC O
bleeding JJ B-Sign_symptom
episodes NNS I-Sign_symptom
. . O

Table JJ O
1 CD O
shows VBZ O
the DT O
laboratory NN O
data NNS O
on IN O
admission NN O
. . O

The DT O
platelet NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
associated VBN I-Diagnostic_procedure
IgG NNP I-Diagnostic_procedure
level NN I-Diagnostic_procedure
was VBD O
markedly RB B-Detailed_description
high JJ B-Lab_value
. . O

Bone NNP B-Biological_structure
marrow NN I-Biological_structure
biopsy NN B-Diagnostic_procedure
revealed VBD O
normocellular JJ B-Sign_symptom
marrow NN I-Sign_symptom
without IN O
cellular JJ B-Sign_symptom
atypia NN I-Sign_symptom
. . O

Ultrasonography NN B-Diagnostic_procedure
and CC O
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
revealed VBD O
a DT O
cirrhotic JJ B-Sign_symptom
liver NN B-Biological_structure
with IN O
splenomegaly NN B-Sign_symptom
, , O
ascites NNS B-Sign_symptom
, , O
and CC O
gallstones NNS B-Sign_symptom
. . O

The DT O
spleen JJ B-Diagnostic_procedure
size NN I-Diagnostic_procedure
had VBD O
remained VBN O
unchanged JJ B-Lab_value
from IN O
previous JJ B-Detailed_description
imaging VBG B-Diagnostic_procedure
examinations NNS I-Diagnostic_procedure
. . O

Based VBN O
on IN O
these DT O
findings NNS O
, , O
the DT O
association NN O
of IN O
PBC NNP B-Disease_disorder
( ( O
decompensated VBN B-Disease_disorder
liver RB I-Disease_disorder
cirrhosis NN I-Disease_disorder
) ) O
with IN O
ITP NNP B-Disease_disorder
was VBD O
diagnosed VBN O
. . O

Human NNP B-Diagnostic_procedure
leukocyte NN I-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
( ( I-Diagnostic_procedure
HLA NNP I-Diagnostic_procedure
) ) I-Diagnostic_procedure
genotyping VBG I-Diagnostic_procedure
determined VBN O
by IN O
polymerase NN B-Diagnostic_procedure
chain NN I-Diagnostic_procedure
reaction NN I-Diagnostic_procedure
- : I-Diagnostic_procedure
sequencing VBG I-Diagnostic_procedure
- : I-Diagnostic_procedure
based VBN I-Diagnostic_procedure
typing NN I-Diagnostic_procedure
or CC O
polymerase NN B-Diagnostic_procedure
chain NN I-Diagnostic_procedure
reaction NN I-Diagnostic_procedure
- : I-Diagnostic_procedure
sequence NN I-Diagnostic_procedure
specific JJ I-Diagnostic_procedure
primers NNS I-Diagnostic_procedure
( ( O
SRL NNP O
, , O
Inc NNP O
. . O
, , O
Tokyo NNP O
, , O
Japan NNP O
) ) O
detected VBD O
A NNP B-Sign_symptom
* NNP I-Sign_symptom
02010101 CD I-Sign_symptom
, , O
B NNP B-Sign_symptom
* NNP I-Sign_symptom
400201 CD I-Sign_symptom
, , O
C NNP B-Sign_symptom
* NNP I-Sign_symptom
030401 CD I-Sign_symptom
, , O
C NNP B-Sign_symptom
* NNP I-Sign_symptom
07020101 CD I-Sign_symptom
, , O
DPB1 NNP B-Sign_symptom
* NNP I-Sign_symptom
0501 CD I-Sign_symptom
, , O
DQA1 NNP B-Sign_symptom
* NNP I-Sign_symptom
0103 CD I-Sign_symptom
, , O
DQA1 NNP B-Sign_symptom
* NNP I-Sign_symptom
030101 CD I-Sign_symptom
, , O
DQB1 NNP B-Sign_symptom
* NNP I-Sign_symptom
030201 CD I-Sign_symptom
, , O
DQB1 NNP B-Sign_symptom
* NNP I-Sign_symptom
060101 CD I-Sign_symptom
, , O
DRB1 NNP B-Sign_symptom
* NNP I-Sign_symptom
080201 CD I-Sign_symptom
, , O
and CC O
DRB1 NNP B-Sign_symptom
* NNP I-Sign_symptom
080302 CD I-Sign_symptom
. . O

The DT O
13C CD B-Diagnostic_procedure
urea JJ I-Diagnostic_procedure
breath NN I-Diagnostic_procedure
test NN I-Diagnostic_procedure
for IN O
H NNP B-Diagnostic_procedure
pylori JJ I-Diagnostic_procedure
infection NN I-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
. . O

Figure NN O
2 CD O
shows VBZ O
the DT O
clinical JJ O
course NN O
. . O

Oral NNP O
prednisolone NN B-Medication
, , O
30 CD B-Dosage
mg JJ I-Dosage
daily RB B-Frequency
, , O
for IN O
ITP NNP O
was VBD O
started VBN O
on IN O
day NN O
11 CD O
, , O
and CC O
diuretic JJ B-Medication
therapy NN I-Medication
combined VBN O
with IN O
albumin JJ B-Medication
infusion NN I-Medication
for IN O
ascites NNS B-Sign_symptom
was VBD O
performed VBN O
. . O

As IN O
the DT O
platelet NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
did VBD B-Lab_value
not RB I-Lab_value
increase VB I-Lab_value
notably RB I-Lab_value
, , O
pulse JJ B-Medication
therapy NN I-Medication
with IN O
intravenous JJ O
methylprednisolone NN B-Medication
, , O
1 CD B-Dosage
g JJ I-Dosage
daily RB B-Frequency
, , O
was VBD O
added VBN O
on IN O
d NN B-Duration
22 CD I-Duration
to TO I-Duration
24 CD I-Duration
. . O

However RB O
, , O
the DT O
response NN O
was VBD O
weak JJ B-Lab_value
and CC O
temporary JJ B-Detailed_description
. . O

On IN O
d NN O
31 CD O
, , O
mild FW B-Severity
melena NN B-Sign_symptom
was VBD O
identified VBN O
. . O

The DT O
patient NN O
was VBD O
given VBN O
a DT O
trial NN B-Detailed_description
of IN O
intravenous JJ O
immune JJ B-Medication
gamma NN I-Medication
globulin NN I-Medication
therapy NN I-Medication
, , O
25 CD B-Dosage
g JJ I-Dosage
daily RB B-Frequency
, , O
on IN O
d NN B-Duration
32 CD I-Duration
to TO I-Duration
36 CD I-Duration
, , O
combined VBN O
with IN O
a DT O
second JJ B-Detailed_description
round NN I-Detailed_description
of IN O
intravenous JJ O
methylprednisolone NN B-Medication
pulse JJ I-Medication
therapy NN I-Medication
on IN O
d NN B-Duration
32 CD I-Duration
to TO I-Duration
34 CD I-Duration
. . O

Because IN O
a DT O
moderate JJ B-Lab_value
response NN O
was VBD O
observed VBN O
, , O
prednisolone NN B-Medication
was VBD O
continued VBN O
, , O
and CC O
the DT O
platelet NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
increased VBD B-Lab_value
slowly RB I-Lab_value
. . O

The DT O
ascites NNS B-Sign_symptom
was VBD I-Sign_symptom
relatively RB I-Sign_symptom
well RB I-Sign_symptom
controlled VBN I-Sign_symptom
with IN O
diuretics NNS B-Medication
at IN O
discharge NN O
. . O

Considering VBG O
the DT O
decompensated VBN B-Disease_disorder
liver NN I-Disease_disorder
cirrhosis NN I-Disease_disorder
and CC O
the DT O
platelet NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
, , O
we PRP O
determined VBD O
the DT O
patient NN O
required VBN O
careful JJ O
follow SYM O
- : O
up IN O
of IN O
esophageal JJ B-Sign_symptom
varices NNS I-Sign_symptom
without IN O
prophylactic JJ B-Therapeutic_procedure
endoscopic NN I-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
. . O

-DOCSTART- NN -X-

An DT O
81 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
female NN O
with IN O
hypertension NN O
and CC O
gout NN O
was VBD O
admitted VBN O
to TO O
Taichung NNP B-Nonbiological_location
Veterans NNP I-Nonbiological_location
General NNP I-Nonbiological_location
Hospital NNP I-Nonbiological_location
due JJ O
to TO O
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
and CC O
hematemesis NN B-Sign_symptom
. . O

She PRP O
began VBD O
to TO O
suffer VB O
from IN O
intermittent JJ B-Detailed_description
epigastralgia NN B-Sign_symptom
more JJR O
than IN O
10 CD O
years NNS O
ago RB O
, , O
and CC O
a DT O
4 CD B-Distance
cm NN I-Distance
gastric JJ B-Biological_structure
tumor NN B-Sign_symptom
was VBD O
found VBN O
. . O

The DT O
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
got VBD B-Lab_value
worse JJR I-Lab_value
2 CD O
years NNS O
before IN O
admission NN O
, , O
and CC O
she PRP O
went VBD O
to TO O
a DT O
local JJ B-Nonbiological_location
hospital NN I-Nonbiological_location
where WRB O
abdominal JJ B-Biological_structure
CT NNP B-Diagnostic_procedure
scan NN O
revealed VBD O
a DT O
gastric JJ B-Biological_structure
tumor NN B-Sign_symptom
about IN O
6 CD B-Distance
cm NNS I-Distance
in IN O
length NN O
with IN O
well RB B-Detailed_description
- : I-Detailed_description
circumscribed VBN I-Detailed_description
calcification NN I-Detailed_description
( ( O
figure JJ O
1 CD O
) ) O
. . O

Surgical JJ B-Therapeutic_procedure
intervention NN I-Therapeutic_procedure
was VBD O
suggested VBN O
, , O
but CC O
she PRP O
declined VBD O
. . O

About IN O
10 CD O
days NNS O
before IN O
admission NN O
, , O
tarry JJ B-Sign_symptom
stool JJ I-Sign_symptom
passage NN O
was VBD O
noted VBN O
, , O
and CC O
bloody NN B-Sign_symptom
vomitus NN I-Sign_symptom
was VBD O
found VBN O
1 CD O
day NN O
later RB O
. . O

UGI NNP B-Diagnostic_procedure
scope NN I-Diagnostic_procedure
revealed VBD O
submucosal JJ B-Biological_structure
gastric JJ B-Biological_structure
tumor NN B-Sign_symptom
with IN O
central JJ B-Detailed_description
ulceration NN I-Detailed_description
and CC O
she PRP O
was VBD O
then RB O
transferred VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
upper JJ B-Biological_structure
abdominal JJ I-Biological_structure
tenderness NN B-Sign_symptom
with IN O
mild JJ B-Severity
muscle NN B-Biological_structure
guarding NN B-Sign_symptom
. . O

The DT O
plain NN B-Detailed_description
radiography NN B-Diagnostic_procedure
showed VBD O
an DT O
irregular JJ B-Shape
shape NN I-Shape
calcification NN B-Sign_symptom
over IN O
upper JJ B-Biological_structure
abdomen NNS I-Biological_structure
. . O

UGI NNP B-Diagnostic_procedure
scope NN I-Diagnostic_procedure
revealed VBD O
deep JJ B-Biological_structure
gastric JJ I-Biological_structure
ulcer NN B-Sign_symptom
with IN O
foreign JJ B-Sign_symptom
body NN I-Sign_symptom
. . O

CT NNP B-Diagnostic_procedure
scan JJ O
showed VBD O
an DT O
irregularly JJ B-Shape
shaped VBD I-Shape
space NN B-Detailed_description
- : I-Detailed_description
occupying VBG I-Detailed_description
lesion NN B-Sign_symptom
in IN O
front NN O
of IN O
the DT O
stomach NN B-Biological_structure
with IN O
plate NN B-Detailed_description
calcifications NNS I-Detailed_description
and CC O
localized VBD B-Detailed_description
free JJ B-Sign_symptom
air NN I-Sign_symptom
( ( O
figures VBZ O
2 CD O
and CC O
3 CD O
) ) O
. . O

Under IN O
the DT O
impression NN O
of IN O
perforated JJ O
gastric JJ O
tumor NN O
, , O
emergent JJ B-Detailed_description
laparotomy NN B-Diagnostic_procedure
was VBD O
performed VBN O
. . O

An DT O
infiltrative JJ B-Detailed_description
mass NN B-Sign_symptom
between IN O
the DT O
stomach NN B-Biological_structure
and CC O
transverse NN B-Biological_structure
colon NN I-Biological_structure
was VBD O
noted VBN O
during IN O
operation NN O
. . O

A DT O
sharp JJ B-Detailed_description
, , O
bone SYM B-Detailed_description
- : I-Detailed_description
like IN I-Detailed_description
and CC O
thick VB B-Detailed_description
calcified JJ B-Sign_symptom
plate NN I-Sign_symptom
penetrating NN O
into IN O
the DT O
gastric JJ B-Biological_structure
mucosa NN I-Biological_structure
and CC O
pericolic JJ B-Biological_structure
soft JJ I-Biological_structure
tissue NN I-Biological_structure
was VBD O
observed VBN O
. . O

A DT O
submucosal JJ B-Biological_structure
tumor NN B-Sign_symptom
about IN O
2 CD B-Distance
. . I-Distance
3 CD I-Distance
cm NN I-Distance
in IN O
size NN O
adherent NN O
to TO O
the DT O
calcified JJ O
plate NN O
was VBD O
also RB O
noted VBN O
( ( O
figures NNS O
4 CD O
and CC O
5 CD O
) ) O
. . O

Distal NNP B-Detailed_description
subtotal JJ B-Detailed_description
gastrectomy NN B-Therapeutic_procedure
and CC O
partial JJ B-Detailed_description
colectomy NN B-Therapeutic_procedure
were VBD O
performed VBN O
. . O

The DT O
patient NN O
was VBD O
discharged VBN O
13 CD O
days NNS O
after IN O
operation NN O
uneventfully RB O
. . O

Microscopically RB B-Diagnostic_procedure
, , O
spindle JJ B-Shape
- : I-Shape
shaped JJ I-Shape
tumor NN B-Sign_symptom
cells NNS I-Sign_symptom
with IN O
low JJ B-Lab_value
mitotic JJ B-Diagnostic_procedure
frequency NN I-Diagnostic_procedure
( ( O
4 CD B-Lab_value
/ RB I-Lab_value
50 CD I-Lab_value
HPF NNP I-Lab_value
) ) O
were VBD O
found VBN O
. . O

Immunohistochemical JJ B-Diagnostic_procedure
staining NN I-Diagnostic_procedure
of IN O
the DT O
tumor NN O
demonstrated VBD O
diffusely RB B-Lab_value
strong JJ I-Lab_value
positive JJ I-Lab_value
reactivity NN O
for IN O
CD NN B-Diagnostic_procedure
117 CD I-Diagnostic_procedure
, , O
positive JJ B-Lab_value
reactivity NN O
for IN O
CD34 NNP B-Diagnostic_procedure
, , O
but CC O
negative JJ B-Lab_value
reactivity NN O
for IN O
S100 NNP B-Diagnostic_procedure
protein NN I-Diagnostic_procedure
and CC O
desmin NN B-Diagnostic_procedure
. . O

The DT O
diagnosis NN O
of IN O
the DT O
tumor NN O
was VBD O
established VBN O
as IN O
GIST NNP B-Disease_disorder
. . O

Due JJ O
to TO O
the DT O
small JJ O
size NN O
and CC O
the DT O
paucity NN O
of IN O
mitotic JJ O
figures NNS O
of IN O
the DT O
tumor NN O
located VBN O
in IN O
the DT O
stomach NN O
, , O
it PRP O
was VBD O
classified VBN O
as IN O
very RB B-Lab_value
low JJ I-Lab_value
risk NN I-Lab_value
[ VBD O
4 CD O
] NN O
. . O

Sporadic JJ O
GIST NNP O
was VBD O
impressed JJ O
due JJ O
to TO O
no DT O
family NN O
history NN O
of IN O
GIST NNP O
nor CC O
other JJ O
GIST NNP O
presented VBN O
in IN O
this DT O
patient NN O
. . O

-DOCSTART- NN -X-

A DT O
36 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
female NN O
presented VBN O
at IN O
the DT O
emergency NN B-Nonbiological_location
department NN I-Nonbiological_location
with IN O
aggravating VBG B-Detailed_description
right JJ B-Biological_structure
upper JJ I-Biological_structure
abdominal JJ I-Biological_structure
pain NN B-Sign_symptom
for IN O
2 CD B-Duration
hours NNS I-Duration
. . O

The DT O
patient NN O
was VBD O
diagnosed VBN O
hepatitis NN O
B NNP O
virus NN O
( ( O
HBV NNP O
) ) O
carrier NN O
for IN O
several JJ O
years NNS O
and CC O
non SYM O
- : O
alcoholics NNS O
. . O

No DT O
other JJ O
specific JJ O
personal JJ O
and CC O
familial JJ O
medical JJ O
history NN O
was VBD O
noted VBN O
. . O

Initial JJ O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
100 CD B-Lab_value
/ JJ I-Lab_value
60 CD I-Lab_value
mmHg NN I-Lab_value
, , O
pulse JJ B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
70 CD B-Lab_value
/ NN I-Lab_value
min NN I-Lab_value
, , O
respiration NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
20 CD B-Lab_value
/ NN I-Lab_value
min NN I-Lab_value
, , O
body NN B-Diagnostic_procedure
temperature NN I-Diagnostic_procedure
37 CD B-Lab_value
. . I-Lab_value
5 CD I-Lab_value
℃ NN I-Lab_value
. . O

The DT O
laboratory NN B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
were VBD O
white JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
12,000 CD B-Lab_value
/ NN I-Lab_value
mm3 NN I-Lab_value
( ( O
poly NN B-Diagnostic_procedure
: : O
70 CD B-Lab_value
% NN I-Lab_value
) ) O
, , O
hemoglobin $ B-Diagnostic_procedure
12 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
platelet NN B-Diagnostic_procedure
198,000 CD B-Lab_value
/ NN I-Lab_value
mm3 NN I-Lab_value
, , O
prothrombin JJ B-Diagnostic_procedure
time NN I-Diagnostic_procedure
14 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
seconds NNS I-Lab_value
, , O
international JJ B-Diagnostic_procedure
normalized VBN I-Diagnostic_procedure
ratio NN I-Diagnostic_procedure
1 CD B-Lab_value
. . I-Lab_value
11 CD I-Lab_value
, , O
aspartate JJ B-Diagnostic_procedure
aminotransferase NN I-Diagnostic_procedure
22 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
alanine JJ B-Diagnostic_procedure
aminotransferase NN I-Diagnostic_procedure
12 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
total JJ B-Diagnostic_procedure
bilirubin NN I-Diagnostic_procedure
0 CD B-Lab_value
. . I-Lab_value
5 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
alkaline JJ B-Diagnostic_procedure
phosphatase NN I-Diagnostic_procedure
134 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
lactate JJ B-Diagnostic_procedure
dehydrogenase NN I-Diagnostic_procedure
295 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
gamma SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
glutamyl NN I-Diagnostic_procedure
transpeptidase NN I-Diagnostic_procedure
26 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
protein NN B-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
albumin VBZ I-Diagnostic_procedure
6 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
/ JJ I-Lab_value
4 CD I-Lab_value
. . I-Lab_value
0 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
uric JJ B-Diagnostic_procedure
acid NN I-Diagnostic_procedure
5 CD B-Lab_value
. . I-Lab_value
0 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
blood NN B-Diagnostic_procedure
urea JJ I-Diagnostic_procedure
nitrogen NN I-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
creatinine NN I-Diagnostic_procedure
16 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
/ JJ I-Lab_value
0 CD I-Lab_value
. . I-Lab_value
7 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
. . O

And CC O
serum VB B-Diagnostic_procedure
viral JJ I-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
were VBD O
HBsAg NNP B-Diagnostic_procedure
( ( O
+ NNP B-Lab_value
) ) O
, , O
anti SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
HBs NNP I-Diagnostic_procedure
( ( O
- : B-Lab_value
) ) O
, , O
anti SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
HBc NNP I-Diagnostic_procedure
( ( O
+ NNP B-Lab_value
) ) O
, , O
HBeAg NNP B-Diagnostic_procedure
( ( O
- : B-Lab_value
) ) O
, , O
anti SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
HBe NNP I-Diagnostic_procedure
( ( O
+ NNP B-Lab_value
) ) O
, , O
HBV NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
DNA NN I-Diagnostic_procedure
< VBZ B-Lab_value
20 CD I-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
, , O
anti SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
HCV NNP I-Diagnostic_procedure
( ( O
- : B-Lab_value
) ) O
and CC O
anti $ B-Diagnostic_procedure
- : I-Diagnostic_procedure
HIV NNP I-Diagnostic_procedure
( ( O
- : B-Lab_value
) ) O
. . O

The DT O
patient NN O
` `` O
s JJ O
serum NN B-Diagnostic_procedure
α NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
fetoprotein NN I-Diagnostic_procedure
( ( O
AFP NNP B-Diagnostic_procedure
) ) O
was VBD O
676 CD B-Lab_value
. . I-Lab_value
5 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
and CC O
carbohydrate NN B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
19 CD I-Diagnostic_procedure
- : I-Diagnostic_procedure
9 CD I-Diagnostic_procedure
( ( O
CA19 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
9 CD I-Diagnostic_procedure
) ) O
< NN B-Lab_value
0 CD I-Lab_value
. . I-Lab_value
6 CD I-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
. . O

She PRP O
took VBD O
an DT O
abdominal JJ B-Biological_structure
CT NNP B-Diagnostic_procedure
scan NN O
, , O
which WDT O
showed VBD O
a DT O
9 CD B-Distance
cm NN I-Distance
sized VBN O
necrotic JJ B-Detailed_description
mass NN B-Sign_symptom
with IN B-Detailed_description
internal JJ I-Detailed_description
hemorrhage NN I-Detailed_description
at IN O
the DT O
right JJ B-Biological_structure
hepatic JJ I-Biological_structure
lobe NN I-Biological_structure
and CC O
ruptured VBD B-Biological_structure
to TO I-Biological_structure
peritoneum VB I-Biological_structure
( ( O
Fig NNP O
. . O
1A CD O
) ) O
, , O
so IN O
an DT O
emergency NN B-Detailed_description
hepatic JJ B-Biological_structure
central JJ I-Biological_structure
bisectionectomy NN B-Therapeutic_procedure
was VBD O
done VBN O
( ( O
Fig NNP O
. . O
2A CD O
) ) O
. . O

The DT O
initial JJ O
histological JJ O
diagnosis NN O
was VBD O
cHCC JJ B-Disease_disorder
- : I-Disease_disorder
CC NN I-Disease_disorder
with IN O
spindle JJ B-Detailed_description
cell NN I-Detailed_description
metaplasia NN I-Detailed_description
of IN I-Detailed_description
cholangiocarcinoma NN I-Detailed_description
element NN I-Detailed_description
( ( O
Fig NNP O
. . O
2B CD O
) ) O
. . O

The DT O
serum NN B-Diagnostic_procedure
AFP NNP I-Diagnostic_procedure
was VBD O
decreased VBN B-Lab_value
to TO O
7 CD B-Lab_value
. . I-Lab_value
67 CD I-Lab_value
ng JJ I-Lab_value
/ NN I-Lab_value
mL NN I-Lab_value
at IN O
time NN O
of IN O
discharge NN O
. . O

Regarding VBG O
as IN O
cHCC NN B-Disease_disorder
- : I-Disease_disorder
CC NNP I-Disease_disorder
, , O
postoperative JJ O
adjuvant NN B-Detailed_description
chemotherapy NN B-Medication
with IN O
tegafur JJ B-Medication
/ NNS I-Medication
uracil NN I-Medication
( ( O
UFT NNP B-Medication
) ) O
was VBD O
administrated VBN O
for IN O
3 CD B-Duration
months NNS I-Duration
. . O

3 CD O
months NNS O
later RB O
, , O
follow VB O
- : O
up IN O
abdominal JJ B-Biological_structure
CT NNP B-Diagnostic_procedure
scanning NN O
showed VBD O
previously RB O
unseen JJ O
a DT O
5 CD B-Distance
. . I-Distance
5 CD I-Distance
cm NN I-Distance
sized VBN O
left VBD B-Biological_structure
subphrenic JJ I-Biological_structure
mass NN B-Sign_symptom
with IN O
mild JJ B-Severity
enhancement NN B-Sign_symptom
in IN O
delayed JJ B-Detailed_description
image NN I-Detailed_description
( ( O
Fig NNP O
. . O
3A CD O
, , O
B NNP O
) ) O
and CC O
AFP NNP B-Diagnostic_procedure
was VBD O
increased VBN B-Lab_value
to TO O
312 CD B-Lab_value
. . I-Lab_value
06 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
. . O

She PRP O
underwent JJ O
laparoscopic JJ B-Detailed_description
splenectomy NN B-Therapeutic_procedure
with IN O
mass NN B-Therapeutic_procedure
excision NN I-Therapeutic_procedure
. . O

On IN O
histologic JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
mesenchymal JJ B-Diagnostic_procedure
elements NNS I-Diagnostic_procedure
consisted VBN O
of IN O
a DT O
proliferation NN B-Lab_value
of IN I-Lab_value
primitive JJ I-Lab_value
- : I-Lab_value
appearing VBG I-Lab_value
mesenchymal JJ I-Lab_value
spindle JJ I-Lab_value
- : I-Lab_value
shaped JJ I-Lab_value
cells NNS I-Lab_value
, , O
intimately RB B-Detailed_description
admixed VBN I-Detailed_description
with IN I-Detailed_description
the DT I-Detailed_description
epithelial JJ I-Detailed_description
elements NNS I-Detailed_description
in IN I-Detailed_description
a DT I-Detailed_description
highly RB I-Detailed_description
cellular JJ I-Detailed_description
pattern NN I-Detailed_description
. . O

Cytoplasm NNP B-Diagnostic_procedure
was VBD O
more RBR B-Lab_value
abundant JJ I-Lab_value
than IN I-Lab_value
that DT I-Lab_value
of IN I-Lab_value
mature NN I-Lab_value
fibroblasts NNS I-Lab_value
, , O
and CC O
the DT O
nucleus NN B-Diagnostic_procedure
was VBD O
elongated VBN B-Shape
and CC O
plump NN B-Shape
. . O

These DT O
cells NNS B-Lab_value
blended VBD I-Lab_value
progressively RB I-Lab_value
with IN I-Lab_value
areas NNS I-Lab_value
of IN I-Lab_value
less JJR I-Lab_value
intense JJ I-Lab_value
cellular JJ I-Lab_value
mesenchymal JJ I-Lab_value
proliferation NN I-Lab_value
, , O
and CC O
with IN O
relatively RB B-Detailed_description
acellular JJ I-Detailed_description
, , I-Detailed_description
fibrous JJ I-Detailed_description
septa NN I-Detailed_description
. . O

Osteoid NNP B-Diagnostic_procedure
was VBD O
present JJ B-Lab_value
either RB O
within IN B-Detailed_description
the DT I-Detailed_description
primitive JJ I-Detailed_description
mesenchyme NN I-Detailed_description
, , O
near IN B-Detailed_description
the DT I-Detailed_description
fibrous JJ I-Detailed_description
septa NN I-Detailed_description
or CC I-Detailed_description
pseudocapsule NN I-Detailed_description
, , O
or CC O
admixed RB B-Detailed_description
within IN I-Detailed_description
the DT I-Detailed_description
epithelial JJ I-Detailed_description
elements NNS I-Detailed_description
. . O

Osteoid NNP B-Diagnostic_procedure
foci NN I-Diagnostic_procedure
contained VBD O
cells NNS B-Lab_value
morphologically RB I-Lab_value
identical JJ I-Lab_value
to TO I-Lab_value
osteoblasts NNS I-Lab_value
( ( O
Fig NNP O
. . O
4A CD O
) ) O
. . O

The DT O
immunohistochemistry NN B-Diagnostic_procedure
stains VBZ I-Diagnostic_procedure
showed JJ O
expression NN B-Lab_value
of IN O
hepatocyte NN B-Diagnostic_procedure
, , O
β NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
HCG NNP I-Diagnostic_procedure
, , O
AFP NNP B-Diagnostic_procedure
, , O
vimentin NN B-Diagnostic_procedure
, , O
CK7 NNP B-Diagnostic_procedure
, , O
CK19 NNP B-Diagnostic_procedure
, , O
CD56 NNP B-Diagnostic_procedure
and CC O
β NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
catenin NN I-Diagnostic_procedure
and CC O
negativity NN B-Lab_value
for IN O
CEA NNP B-Diagnostic_procedure
. . O
( ( O
Fig NNP O
. . O
4B CD O
, , O
C NNP O
, , O
D NNP O
, , O
E NNP O
, , O
F NNP O
, , O
G NNP O
) ) O
. . O

Metastatic JJ B-Detailed_description
hepatoblastoma NN B-Disease_disorder
was VBD O
confirmed VBN O
by IN O
histologic JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
with IN O
immunohistochemistry NN B-Diagnostic_procedure
stains NNS I-Diagnostic_procedure
, , O
so RB O
immunohistochemistrically RB O
re JJ O
- : O
examination NN O
of IN O
previous JJ O
surgical JJ O
specimens NNS O
was VBD O
also RB O
confirmed VBN O
as IN O
hepatoblastoma NN O
. . O

Follow NNP O
- : O
up RP O
abdominal JJ B-Biological_structure
CT NNP B-Diagnostic_procedure
scan NN O
performed VBD O
1 CD O
month NN O
after IN O
reoperation NN O
showed VBD O
a DT O
newly RB B-Detailed_description
onset VBN I-Detailed_description
1 CD B-Distance
. . I-Distance
7 CD I-Distance
cm JJ I-Distance
sized VBN O
subtle JJ B-Detailed_description
enhancing VBG I-Detailed_description
soft JJ B-Detailed_description
tissue NN I-Detailed_description
mass NN B-Sign_symptom
in IN O
splenic JJ B-Biological_structure
bed NN I-Biological_structure
, , O
and CC O
positron NN B-Diagnostic_procedure
emission NN I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
PET NNP B-Diagnostic_procedure
) ) O
showed VBD O
multiple JJ B-Detailed_description
FDG NNP B-Detailed_description
uptake NN B-Sign_symptom
( ( O
max JJ B-Lab_value
SUV NNP I-Lab_value
> NNP I-Lab_value
3 CD I-Lab_value
. . I-Lab_value
80 CD I-Lab_value
) ) O
in IN O
left VBN B-Detailed_description
upper JJ I-Detailed_description
and CC O
lower JJR B-Detailed_description
quadrant JJ I-Detailed_description
area NN O
of IN O
abdomen NNS B-Biological_structure
, , O
paralumbar JJ B-Biological_structure
area NN I-Biological_structure
including VBG I-Biological_structure
right JJ I-Biological_structure
subphrenic JJ I-Biological_structure
area NN I-Biological_structure
( ( O
Fig NNP O
. . O
5A CD O
, , O
B NNP O
, , O
C NNP O
) ) O
. . O

Follow NNP O
- : O
up RB O
AFP NNP B-Diagnostic_procedure
was VBD O
162 CD B-Lab_value
. . I-Lab_value
69 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
. . O

Systemic NNP B-Detailed_description
chemotherapy NN B-Medication
started VBD O
with IN O
cisplatin NN B-Medication
( ( O
60 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
m2 NN I-Dosage
) ) O
, , O
5 CD B-Medication
- : I-Medication
fluorourasil NN I-Medication
( ( O
5 CD B-Medication
- : I-Medication
FU NN I-Medication
) ) O
( ( O
600 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
m2 NN I-Dosage
) ) O
, , O
vincristine NN B-Medication
( ( O
1 CD B-Dosage
. . I-Dosage
5 CD I-Dosage
mg JJ I-Dosage
/ NNP I-Dosage
m2 NN I-Dosage
) ) O
and CC O
total JJ O
3 CD B-Frequency
cycles NNS I-Frequency
of IN O
chemotherapy NN O
were VBD O
done VBN O
every DT B-Frequency
4 CD I-Frequency
week NN I-Frequency
. . O

Entecavir RB B-Medication
0 CD B-Dosage
. . I-Dosage
5 CD I-Dosage
mg NN I-Dosage
was VBD O
also RB O
started VBN O
for IN O
chemoprophylaxis NN B-Medication
of IN O
CHB NNP B-Disease_disorder
. . O

After IN O
the DT O
3rd CD O
chemotherapy NN O
cycle NN O
, , O
follow VB O
- : O
up IN O
abdominal JJ B-Biological_structure
CT NNP B-Diagnostic_procedure
and CC O
PET NNP B-Diagnostic_procedure
scan JJ O
showed VBD O
progression NN O
of IN O
multiple JJ B-Detailed_description
intraperitoneal JJ B-Biological_structure
metastasis NN B-Sign_symptom
with IN O
large JJ B-Severity
amount NN I-Severity
of IN O
intraperitoneal JJ B-Biological_structure
fluid NN B-Sign_symptom
( ( O
Fig NNP O
. . O
6A CD O
, , O
B NNP O
) ) O
and CC O
follow $ O
- : O
up IN O
AFP NNP B-Diagnostic_procedure
was VBD O
further RBR O
increased VBN B-Lab_value
to TO O
254 CD B-Lab_value
ng NNS I-Lab_value
/ JJ I-Lab_value
mL NN I-Lab_value
. . O

So RB O
chemotherapy JJ B-Medication
regimen NN O
was VBD O
changed VBN O
to TO O
carboplatin VB B-Medication
( ( O
350 CD B-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
m2 NN I-Lab_value
) ) O
with IN O
doxorubicin NN B-Medication
( ( O
30 CD B-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
m2 NN I-Lab_value
) ) O
every DT B-Frequency
3 CD I-Frequency
weeks NNS I-Frequency
. . O

The DT O
patient NN O
experienced VBD O
neutropenia RB B-Sign_symptom
after IN O
the DT O
new JJ O
regimen NNS O
, , O
but CC O
recovered VBD B-Sign_symptom
shortly RB O
after IN O
treatment NN O
with IN O
granulocyte NN B-Medication
colony NN I-Medication
- : I-Medication
stimulating NN I-Medication
factor NN I-Medication
( ( O
G NNP B-Medication
- : I-Medication
CSF NN I-Medication
) ) O
. . O

After IN O
second JJ O
carboplatin NN O
with IN O
doxorubicin JJ O
chemotherapy NN O
, , O
follow VB O
- : O
up IN O
AFP NNP B-Diagnostic_procedure
was VBD O
increased VBN B-Lab_value
1510 CD B-Lab_value
. . I-Lab_value
19 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
, , O
but CC O
abdominal JJ B-Biological_structure
CT NNP B-Diagnostic_procedure
scan NN O
showed VBD O
that IN O
amount NN O
of IN O
ascites NNS B-Sign_symptom
was VBD O
decreased VBN O
( ( O
Fig NNP O
. . O
7 CD O
) ) O
. . O

Because IN O
of IN O
radiologic JJ O
improvements NNS O
, , O
third JJ O
and CC O
fourth JJ O
chemotherapy NN B-Medication
were VBD O
performed VBN O
. . O

After IN O
4th CD O
chemotherapy NN O
, , O
follow VB O
- : O
up IN O
abdominal JJ B-Biological_structure
CT NNP B-Diagnostic_procedure
revealed VBD O
progression NN O
of IN O
multiple JJ B-Detailed_description
intraperitoneal JJ B-Biological_structure
metastatic JJ B-Detailed_description
masses NNS B-Sign_symptom
, , O
newly RB O
developed VBN O
hepatic JJ B-Biological_structure
metastasis NN B-Sign_symptom
and CC O
large JJ B-Severity
amount NN I-Severity
of IN O
intraperitoneal JJ B-Biological_structure
fluid NN B-Sign_symptom
( ( O
Fig NNP O
. . O
8 CD O
) ) O
. . O

A DT O
diagnostic JJ O
paracentesis NN B-Diagnostic_procedure
was VBD O
performed VBN O
and CC O
showed VBN O
white JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
310 CD B-Lab_value
/ NN I-Lab_value
mm3 NN I-Lab_value
( ( O
poly JJ B-Diagnostic_procedure
20 CD B-Lab_value
% NN I-Lab_value
, , O
lymph JJ B-Diagnostic_procedure
80 CD B-Lab_value
% NN I-Lab_value
) ) O
, , O
protein RB B-Diagnostic_procedure
3 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
and CC O
albumin $ B-Diagnostic_procedure
2 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
on IN O
ascitic JJ B-Diagnostic_procedure
fluid NN I-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
. . O

The DT O
serum NN B-Diagnostic_procedure
albumin NN I-Diagnostic_procedure
was VBD O
3 CD B-Lab_value
. . I-Lab_value
1 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
and CC O
serum NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
ascites VBZ I-Diagnostic_procedure
albumin JJ I-Diagnostic_procedure
gradient NN I-Diagnostic_procedure
( ( O
SAAG NNP B-Diagnostic_procedure
) ) O
was VBD O
0 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
. . O

The DT O
AFB NNP B-Diagnostic_procedure
stain NN I-Diagnostic_procedure
and CC I-Diagnostic_procedure
culture NN I-Diagnostic_procedure
were VBD O
all DT O
negative JJ B-Lab_value
in IN O
ascitic JJ B-Detailed_description
fluid NN I-Detailed_description
. . O

The DT O
AFP NNP B-Diagnostic_procedure
was VBD O
6881 CD B-Lab_value
. . I-Lab_value
93 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
on IN O
serum NN B-Detailed_description
. . O

Regarded VBN O
as IN O
peritoneal JJ B-Biological_structure
carcinomatosis NN B-Disease_disorder
, , O
the DT O
patient JJ O
underwent JJ O
conservative JJ B-Therapeutic_procedure
treatments NNS I-Therapeutic_procedure
including VBG O
the DT O
use NN O
of IN O
repeated VBN B-Detailed_description
therapeutic JJ B-Therapeutic_procedure
paracentesis NN I-Therapeutic_procedure
for IN O
1 CD B-Duration
month NN I-Duration
before IN O
death NN O
. . O

-DOCSTART- NN -X-

A DT O
26 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
of IN O
Portuguese JJ O
descent NN O
with IN O
no DT O
significant JJ O
past JJ O
medical JJ O
history NN O
presents NNS O
with IN O
subacute JJ O
onset NN O
of IN O
right JJ B-Detailed_description
- : I-Detailed_description
sided VBN I-Detailed_description
hemiparesis NN B-Sign_symptom
and CC O
aphasia NN B-Disease_disorder
, , O
with IN O
marked JJ B-Severity
expressive JJ B-Detailed_description
aphasia NN B-Disease_disorder
, , O
word NN B-Sign_symptom
- : I-Sign_symptom
finding NN I-Sign_symptom
difficulty NN I-Sign_symptom
, , O
and CC O
rare JJ B-Frequency
paraphrasic JJ B-Sign_symptom
errors NNS I-Sign_symptom
. . O

Examination NN B-Diagnostic_procedure
demonstrated VBD O
right JJ B-Biological_structure
central JJ I-Biological_structure
facial JJ I-Biological_structure
weakness NN B-Sign_symptom
, , O
2 CD B-Lab_value
- : I-Lab_value
3 CD I-Lab_value
/ $ I-Lab_value
5 CD I-Lab_value
strength NN B-Diagnostic_procedure
in IN O
the DT O
right JJ B-Detailed_description
arm NN B-Biological_structure
and CC O
leg NN B-Biological_structure
, , O
and CC O
dysmetria NNS B-Sign_symptom
in IN O
the DT O
right JJ B-Detailed_description
upper NN B-Detailed_description
and CC O
lower JJR B-Detailed_description
extremities NNS B-Biological_structure
. . O

Reflexes NNS B-Diagnostic_procedure
were VBD O
hyperactive JJ B-Lab_value
on IN O
the DT O
right NN B-Detailed_description
with IN O
a DT O
right JJ B-Lab_value
- : I-Lab_value
sided VBD I-Lab_value
Babinski NNP B-Diagnostic_procedure
response NN I-Diagnostic_procedure
. . O

MRI NNP B-Diagnostic_procedure
of IN O
the DT O
brain NN B-Biological_structure
showed VBD O
multiple JJ B-Detailed_description
bilateral JJ B-Detailed_description
concentric NN B-Detailed_description
ring VBG B-Shape
- : I-Shape
like IN I-Shape
structures NNS B-Sign_symptom
in IN O
the DT O
centrum NN B-Biological_structure
semiovale NN I-Biological_structure
and CC O
the DT O
corona NN B-Biological_structure
radiata NN I-Biological_structure
on IN O
T2 NNP B-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
( ( O
figure NN O
, , O
A NNP O
) ) O
, , O
consistent JJ O
with IN O
the DT O
pattern NN O
of IN O
Balo NNP B-Disease_disorder
concentric JJ I-Disease_disorder
sclerosis NN I-Disease_disorder
. . O

There EX O
was VBD O
associated VBN B-Detailed_description
restricted JJ I-Detailed_description
diffusion NN I-Detailed_description
in IN O
3 CD B-Lab_value
lesions NNS B-Sign_symptom
and CC O
incomplete JJ B-Detailed_description
ring NN I-Detailed_description
enhancement NN I-Detailed_description
in IN O
1 CD B-Lab_value
lesion NN B-Sign_symptom
. . O

CSF NNP B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
showed VBD O
30 CD B-Lab_value
leukocytes NNS B-Diagnostic_procedure
( ( O
79 CD B-Lab_value
% NN I-Lab_value
lymphocytes NNS B-Diagnostic_procedure
, , O
4 CD B-Lab_value
% NN I-Lab_value
monocytes NNS B-Diagnostic_procedure
) ) O
, , O
erythrocyte JJ B-Diagnostic_procedure
count NN O
was VBD O
850 CD B-Lab_value
, , O
and CC O
oligoclonal JJ B-Diagnostic_procedure
bands NNS I-Diagnostic_procedure
were VBD O
absent JJ B-Lab_value
. . O

He PRP O
was VBD O
treated VBN O
with IN O
1 CD B-Dosage
g NN I-Dosage
of IN O
IV NNP O
methylprednisolone FW B-Medication
daily RB B-Dosage
for IN O
5 CD B-Duration
days NNS I-Duration
, , O
with IN O
little JJ O
improvement NN O
. . O

He PRP O
then RB O
underwent VBD O
5 CD B-Lab_value
plasmapheresis NN B-Therapeutic_procedure
exchanges NNS I-Therapeutic_procedure
, , O
with IN O
significant JJ B-Lab_value
improvement NN I-Lab_value
of IN O
motor NN B-Diagnostic_procedure
, , O
sensory NN B-Diagnostic_procedure
, , O
speech NN B-Disease_disorder
deficits NNS I-Disease_disorder
, , O
and CC O
gait NN B-Diagnostic_procedure
. . O

Forty NNP O
- : O
five CD O
days NNS O
after IN O
discharge NN O
, , O
his PRP$ O
examination NN B-Diagnostic_procedure
showed VBD O
4 CD B-Lab_value
+ NNP I-Lab_value
/ VBD I-Lab_value
5 CD I-Lab_value
strength NN B-Diagnostic_procedure
in IN O
the DT O
right JJ B-Biological_structure
intrinsic JJ I-Biological_structure
muscles NNS I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
hand NN I-Biological_structure
and CC O
a DT O
right JJ B-Detailed_description
- : I-Detailed_description
sided VBD I-Detailed_description
positional JJ B-Sign_symptom
tremor NN I-Sign_symptom
. . O

Gait NNP B-Diagnostic_procedure
and CC O
tandem JJ B-Detailed_description
gait NN B-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

He PRP O
was VBD O
placed VBN O
on IN O
β NNP B-Medication
- : I-Medication
interferon NN I-Medication
- : I-Medication
1a CD I-Medication
44 CD B-Dosage
μg NN I-Dosage
subcutaneously RB O
3 CD B-Dosage
times NNS I-Dosage
a DT I-Dosage
week NN I-Dosage
, , O
for IN O
treatment NN O
of IN O
presumed VBN O
clinically RB B-Disease_disorder
isolated JJ I-Disease_disorder
syndrome NN I-Disease_disorder
, , O
with IN O
good JJ B-Lab_value
response NN B-Diagnostic_procedure
. . O

One CD O
year NN O
later RB O
, , O
his PRP$ O
neurologic JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
was VBD O
essentially RB B-Lab_value
normal JJ I-Lab_value
. . O

There EX O
was VBD O
no DT O
family NN O
history NN O
of IN O
demyelinating VBG O
or CC O
autoimmune JJ O
disorders NNS O
. . O

His PRP$ O
mother NN O
has VBZ O
a DT O
significant JJ O
history NN O
of IN O
headaches NNS O
and CC O
early JJ O
- : O
onset NN O
strokes NNS O
, , O
and CC O
was VBD O
found VBN O
to TO O
be VB O
a DT O
carrier NN O
of IN O
the DT O
Notch3 NNP O
mutation NN O
consistent NN O
with IN O
cerebral JJ O
autosomal JJ O
dominant JJ O
arteriopathy NN O
with IN O
subcortical JJ O
infarcts NNS O
and CC O
leukoencephalopathy NN O
( ( O
CADASIL NNP O
) ) O
. . O

His PRP$ O
sister NN O
had VBD O
a DT O
stroke NN O
in IN O
her PRP$ O
30s CD O
, , O
and CC O
a DT O
history NN O
of IN O
migraine NN O
headaches NNS O
, , O
but CC O
has VBZ O
not RB O
undergone JJ O
medical JJ O
evaluation NN O
. . O

Testing VBG B-Diagnostic_procedure
for IN I-Diagnostic_procedure
CADASIL NNP I-Diagnostic_procedure
in IN O
the DT O
patient NN O
showed VBD B-Lab_value
the DT O
Notch3 NNP B-Diagnostic_procedure
mutation NN I-Diagnostic_procedure
associated VBN B-Detailed_description
with IN I-Detailed_description
CADASIL NNP I-Detailed_description
( ( O
transition NN B-Detailed_description
C NNP I-Detailed_description
> NNP I-Detailed_description
T NNP I-Detailed_description
, , I-Detailed_description
nucleotide IN I-Detailed_description
position NN I-Detailed_description
1750 CD I-Detailed_description
, , I-Detailed_description
codon VBZ I-Detailed_description
558 CD I-Detailed_description
) ) O
. . O

Skin NNP B-Biological_structure
biopsy NN B-Diagnostic_procedure
showed VBD O
electron SYM B-Detailed_description
- : I-Detailed_description
dense NN I-Detailed_description
extracellular JJ B-Detailed_description
material NN B-Sign_symptom
in IN O
close JJ O
apposition NN O
to TO O
the DT O
smooth JJ B-Biological_structure
muscle NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
vascular JJ I-Biological_structure
media1 NN I-Biological_structure
( ( O
figure NN O
, , O
B NNP O
) ) O
. . O

-DOCSTART- NN -X-

The DT O
31 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
white JJ O
primipara NN O
with IN O
twin JJ O
pregnancy NN O
was VBD O
admitted VBN O
to TO O
hospital VB O
in IN O
the DT O
38th CD O
week NN O
of IN O
gestation NN O
with IN O
elevated JJ B-Sign_symptom
blood NN I-Sign_symptom
pressure NN I-Sign_symptom
( ( O
150 CD B-Lab_value
/ RB I-Lab_value
100 CD I-Lab_value
mmHg NN I-Lab_value
) ) O
. . O

After IN O
receiving VBG O
antihypertensive JJ B-Medication
treatment NN I-Medication
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
120 CD B-Lab_value
/ JJ I-Lab_value
80 CD I-Lab_value
. . O

All DT O
laboratory NN B-Diagnostic_procedure
variables NNS I-Diagnostic_procedure
, , I-Diagnostic_procedure
including VBG I-Diagnostic_procedure
plasma NN I-Diagnostic_procedure
proteins NNS I-Diagnostic_procedure
, , O
were VBD O
within IN B-Lab_value
their PRP$ I-Lab_value
respective JJ I-Lab_value
reference NN I-Lab_value
intervals NNS I-Lab_value
. . O

Few JJ B-Time
hours NNS I-Time
after IN I-Time
admission NN I-Time
to TO I-Time
the DT I-Time
hospital NN I-Time
the DT O
contractions NNS B-Sign_symptom
started VBD I-Sign_symptom
, , O
and CC O
the DT O
caesarean JJ B-Therapeutic_procedure
section NN I-Therapeutic_procedure
was VBD O
performed VBN O
because IN O
of IN O
vertex JJ B-Sign_symptom
- : I-Sign_symptom
transverse JJ I-Sign_symptom
presentation NN I-Sign_symptom
of IN I-Sign_symptom
twins NNS I-Sign_symptom
. . O

Liveborn NNP O
female NN O
and CC O
male NN O
were VBD O
delivered VBN B-Therapeutic_procedure
. . O

The DT O
postoperative JJ B-Detailed_description
course NN I-Detailed_description
was VBD O
initially RB O
inconspicuous JJ B-Sign_symptom
. . O

Four CD B-Time
hours NNS I-Time
postpartum IN I-Time
she PRP O
experienced VBD O
sudden JJ B-Detailed_description
epigastric JJ B-Sign_symptom
pain NN I-Sign_symptom
. . O

The DT O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
rose VBD O
to TO O
190 CD B-Lab_value
/ NNS I-Lab_value
130 CD I-Lab_value
. . O

Laboratory NN B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
showed VBD O
haemolysis NN B-Sign_symptom
, , O
thrombocytopenia NN B-Sign_symptom
, , O
and CC O
an DT O
increase NN B-Lab_value
in IN O
serum JJ B-Diagnostic_procedure
creatinine NN I-Diagnostic_procedure
and CC O
aminotransferases NNS B-Diagnostic_procedure
( ( O
Table NNP O
I PRP O
) ) O
. . O

Intravenous JJ O
magnesium NN B-Medication
sulphate NN I-Medication
was VBD O
administered VBN O
. . O

Abdominal NNP B-Diagnostic_procedure
ultrasound NN I-Diagnostic_procedure
disclosed VBD O
an DT O
empty JJ B-Detailed_description
uterine JJ B-Biological_structure
cavity NN I-Biological_structure
without IN O
placenta NN B-Sign_symptom
residue NN I-Sign_symptom
. . O

Five CD B-Time
hours NNS I-Time
postpartum NN I-Time
, , O
the DT O
patient NN O
was VBD O
transferred VBN O
to TO O
the DT O
intensive JJ B-Nonbiological_location
care NN I-Nonbiological_location
unit NN I-Nonbiological_location
because IN O
of IN O
poor JJ B-Sign_symptom
urine JJ I-Sign_symptom
output NN I-Sign_symptom
, , O
drowsiness NN B-Sign_symptom
, , O
and CC O
suspicion NN B-Detailed_description
of IN O
DIC NNP B-Disease_disorder
. . O

On IN O
examination NN B-Diagnostic_procedure
she PRP O
was VBD O
sleepy JJ B-Sign_symptom
and CC O
disoriented VBN B-Sign_symptom
. . O

The DT O
combination NN O
of IN O
haemolysis NN O
, , O
thrombocytopenia NN O
, , O
and CC O
elevated VBD O
liver NN O
enzymes RB O
suggested VBD O
a DT O
postpartum NN B-Disease_disorder
HELLP NNP I-Disease_disorder
syndrome NN I-Disease_disorder
, , O
complicated VBN O
by IN O
DIC NNP O
. . O

The DT O
patient NN O
was VBD O
rehydrated VBN B-Therapeutic_procedure
, , O
and CC O
treatment NN B-Therapeutic_procedure
was VBD O
instituted VBN O
with IN O
fresh JJ B-Detailed_description
frozen JJ B-Detailed_description
plasma NN B-Therapeutic_procedure
, , O
red JJ B-Biological_structure
cell NN I-Biological_structure
transfusion NN B-Therapeutic_procedure
, , O
fresh JJ B-Detailed_description
platelets NNS B-Therapeutic_procedure
, , O
and CC O
kybernin VB B-Therapeutic_procedure
P NNP I-Therapeutic_procedure
( ( O
antithrombin JJ O
III NNP O
) ) O
. . O

High JJ B-Lab_value
serum NN B-Diagnostic_procedure
urea NN I-Diagnostic_procedure
, , O
creatinine NN B-Diagnostic_procedure
, , O
and CC O
persistent JJ B-Detailed_description
anuria NNS B-Sign_symptom
were VBD O
compatible JJ O
with IN O
acute JJ B-Detailed_description
renal JJ B-Disease_disorder
failure NN I-Disease_disorder
. . O

A DT O
high JJ B-Dosage
dose NN I-Dosage
of IN O
furosemide NN B-Medication
failed VBD O
to TO O
increase VB B-Therapeutic_procedure
diuresis NN I-Therapeutic_procedure
. . O

Sixteen JJ B-Time
hours NNS I-Time
postpartum VBP I-Time
her PRP$ O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
60 CD B-Lab_value
/ JJ I-Lab_value
40 CD I-Lab_value
and CC O
oxygen JJ B-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
70 CD B-Lab_value
% NN I-Lab_value
. . O

Few JJ B-Time
minutes NNS I-Time
later RB I-Time
the DT O
patient NN O
had VBD O
acute JJ B-Detailed_description
cardiac JJ B-Disease_disorder
arrest NN I-Disease_disorder
, , O
and CC O
resuscitation NN B-Therapeutic_procedure
started VBD O
. . O

Resuscitation NN O
was VBD O
successful JJ B-Detailed_description
, , O
and CC O
normal JJ B-Sign_symptom
heart NN I-Sign_symptom
action NN I-Sign_symptom
was VBD O
re JJ O
- : O
established VBN O
; : O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
rose VBD O
to TO O
150 CD B-Lab_value
/ NNS I-Lab_value
110 CD I-Lab_value
, , O
and CC O
oxygen NN B-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
was VBD O
90 CD B-Lab_value
% NN I-Lab_value
. . O

Laboratory JJ B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
were VBD O
deteriorated VBN B-Lab_value
, , O
and CC O
development NN O
of IN O
acute JJ B-Detailed_description
renal JJ O
failure NN O
indicated VBD O
the DT O
necessity NN O
of IN O
urgent JJ B-Detailed_description
dialysis NN B-Therapeutic_procedure
. . O

Following VBG B-Time
dialysis NN I-Time
, , O
the DT O
patient NN O
was VBD O
stable JJ B-Sign_symptom
, , O
oxygen JJ B-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
98 CD B-Lab_value
% NN I-Lab_value
. . O

Twenty CD B-Time
hours NNS I-Time
postpartum JJ I-Time
patient NN O
developed VBD O
again RB O
cardiopulmonary JJ B-Disease_disorder
arrest NN I-Disease_disorder
. . O

Despite IN O
resuscitation NN B-Therapeutic_procedure
attempts VBZ I-Therapeutic_procedure
the DT O
outcome NN O
was VBD O
lethal JJ O
. . O

Due JJ O
to TO O
the DT O
fact NN O
that IN O
death NN O
occurred VBD O
in IN O
the DT O
hospital NN B-Nonbiological_location
a DT O
short JJ B-Time
time NN I-Time
after IN I-Time
a DT I-Time
surgical JJ I-Time
intervention NN I-Time
, , O
a DT O
medico NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
legal JJ I-Diagnostic_procedure
autopsy NN I-Diagnostic_procedure
was VBD O
ordered VBN O
. . O

An DT O
autopsy NN O
revealed VBD O
oedema NN B-Sign_symptom
of IN O
the DT O
brain NN B-Biological_structure
and CC O
lungs NNS B-Biological_structure
as RB O
well RB O
as IN O
dilatation NN B-Sign_symptom
of IN O
right NN B-Biological_structure
and CC I-Biological_structure
left VBD I-Biological_structure
ventricles NNS I-Biological_structure
. . O

Hydrothorax NNP B-Sign_symptom
( ( O
900 CD B-Lab_value
mL NN I-Lab_value
) ) O
, , O
hydroperitoneum NN B-Sign_symptom
( ( O
2500 CD B-Lab_value
mL NN I-Lab_value
) ) O
, , O
and CC O
hydropericardium NN B-Sign_symptom
( ( O
200 CD B-Lab_value
mL NN I-Lab_value
) ) O
were VBD O
present JJ O
. . O

The DT O
field NN O
of IN O
operation NN O
of IN O
the DT O
caesarean JJ B-Therapeutic_procedure
section NN I-Therapeutic_procedure
was VBD O
unremarkable JJ B-Sign_symptom
. . O

Petechial NNP B-Sign_symptom
and CC I-Sign_symptom
suffusional JJ I-Sign_symptom
haemorrhages NNS I-Sign_symptom
were VBD O
observed VBN O
under IN O
the DT O
pleura NN B-Biological_structure
, , O
endocardium NN B-Biological_structure
, , O
in IN O
the DT O
mucosae NN B-Biological_structure
of IN O
the DT O
renal JJ B-Biological_structure
pelvis NN I-Biological_structure
, , O
and CC O
peritoneum NN B-Biological_structure
of IN O
the DT O
small JJ B-Biological_structure
and CC I-Biological_structure
large JJ I-Biological_structure
bowel NN I-Biological_structure
. . O

Histology NNP B-Diagnostic_procedure
revealed VBD O
periportal JJ B-Detailed_description
hepatocellular JJ B-Biological_structure
necrosis NN B-Sign_symptom
, , O
bloodless NN B-Sign_symptom
glomeruli NN B-Biological_structure
with IN I-Sign_symptom
swollen JJ B-Detailed_description
and CC I-Sign_symptom
vacuolated JJ B-Detailed_description
intracapillary JJ B-Biological_structure
cells NNS I-Biological_structure
, , O
as RB O
well RB O
as IN O
confluent NN B-Detailed_description
haemorrhages NNS B-Sign_symptom
in IN O
kidneys NNS B-Biological_structure
, , O
liver NN B-Biological_structure
, , O
and CC O
spleen NN B-Biological_structure
. . O

Death NN O
was VBD O
attributed VBN O
to TO O
multiple VB B-Detailed_description
organ JJ B-Disease_disorder
failure NN I-Disease_disorder
due JJ O
to TO O
DIC NNP B-Disease_disorder
as IN O
a DT O
consequence NN O
of IN O
HELLP NNP B-Disease_disorder
syndrome NN I-Disease_disorder
. . O

-DOCSTART- NN -X-

A DT O
41 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Caucasian JJ O
woman NN O
underwent VBD O
a DT O
primary JJ B-Detailed_description
double JJ B-Detailed_description
lung NN B-Therapeutic_procedure
transplantation NN I-Therapeutic_procedure
for IN O
cystic JJ O
fibrosis NN O
in IN O
2006 CD O
. . O

Her PRP$ O
medical JJ O
history NN O
was VBD O
otherwise RB O
unremarkable JJ O
and CC O
the DT O
patient NN O
had VBD O
no DT O
known JJ O
history NN O
of IN O
pulmonary JJ O
tuberculosis NN O
or CC O
tuberculosis NN O
contact NN O
. . O

On IN O
December NNP O
2015 CD O
, , O
she PRP O
underwent JJ O
retransplantation NN B-Therapeutic_procedure
for IN O
chronic JJ B-Detailed_description
lung NN B-Disease_disorder
allograft NN I-Disease_disorder
dysfunction NN I-Disease_disorder
. . O

During IN O
the DT O
month NN O
preceding VBG O
retransplantation NN O
, , O
4 CD B-Lab_value
sputum NN B-Diagnostic_procedure
specimens NNS I-Diagnostic_procedure
remained VBD O
negative JJ B-Lab_value
for IN O
acid JJ B-Detailed_description
- : I-Detailed_description
fast NN I-Detailed_description
bacilli NN I-Detailed_description
and CC O
specific JJ B-Detailed_description
M NNP I-Detailed_description
. . I-Detailed_description
tuberculosis NN I-Detailed_description
culture NN I-Detailed_description
and CC O
real JJ B-Detailed_description
- : I-Detailed_description
time NN I-Detailed_description
polymerase NN B-Diagnostic_procedure
chain NN I-Diagnostic_procedure
reaction NN I-Diagnostic_procedure
( ( O
PCR NNP B-Diagnostic_procedure
) ) O
testing NN O
. . O

On IN O
postoperative JJ O
day NN O
42 CD O
, , O
deterioration NN B-Lab_value
of IN O
her PRP$ O
respiratory NN B-Diagnostic_procedure
status NN I-Diagnostic_procedure
prompted VBD O
a DT O
chest NN B-Biological_structure
- : O
computerized VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
scan VBD O
revealing VBG O
sub NN B-Detailed_description
- : I-Detailed_description
centimeter NN I-Detailed_description
bilateral JJ B-Detailed_description
nodules NNS B-Sign_symptom
primarily RB O
located VBN O
in IN O
the DT O
apical JJ B-Biological_structure
posterior NN I-Biological_structure
lobes NNS I-Biological_structure
and CC O
a DT O
bilateral JJ B-Detailed_description
pleural JJ B-Disease_disorder
effusion NN I-Disease_disorder
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

The DT O
same JJ O
day NN O
, , O
a DT O
bronchoalveolar JJ B-Diagnostic_procedure
lavage NN I-Diagnostic_procedure
( ( O
BAL NNP B-Diagnostic_procedure
) ) O
yielded VBD O
a DT O
positive JJ B-Lab_value
real JJ B-Detailed_description
- : I-Detailed_description
time NN I-Detailed_description
PCR NNP B-Diagnostic_procedure
for IN O
rifampicin NN B-Detailed_description
- : I-Detailed_description
susceptible JJ I-Detailed_description
M NNP I-Detailed_description
. . I-Detailed_description
tuberculosis NN I-Detailed_description
, , O
confirmed VBN B-Lab_value
by IN O
culture NN B-Diagnostic_procedure
on IN O
postoperative JJ O
day NN O
62 CD O
. . O

Tuberculin NNP B-Diagnostic_procedure
skin JJ I-Diagnostic_procedure
test NN I-Diagnostic_procedure
( ( O
TST NNP B-Diagnostic_procedure
) ) O
or CC O
interferon $ B-Diagnostic_procedure
- : I-Diagnostic_procedure
γ NN I-Diagnostic_procedure
release NN I-Diagnostic_procedure
assay NN I-Diagnostic_procedure
( ( O
IGRA NNP B-Diagnostic_procedure
) ) O
test NN O
were VBD O
not RB O
performed VBN O
. . O

All PDT O
the DT O
BALs NNP B-Diagnostic_procedure
performed VBD O
on IN O
postoperative JJ O
period NN O
yielded VBN O
no DT B-Lab_value
other JJ I-Lab_value
pathogen NN I-Lab_value
except IN O
for IN O
the DT O
one CD O
performed VBN O
on IN O
day NN O
60 CD O
that WDT O
cultured VBD O
Pseudomonas NNP B-Lab_value
aeruginosa NN I-Lab_value
; : O
the DT O
adjunctive JJ B-Detailed_description
antibiotic JJ B-Medication
therapy NN I-Medication
was VBD O
imipenem JJ B-Medication
- : I-Medication
cilastatin NN I-Medication
, , O
3 CD B-Dosage
g NN I-Dosage
/ NNP I-Dosage
d NN I-Dosage
. . O

Histological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
a DT O
lung NN B-Biological_structure
biopsy NN B-Diagnostic_procedure
performed VBD O
6 CD O
weeks NNS O
after IN O
retransplantation NN O
revealed VBD O
a DT O
caseating NN B-Lab_value
granuloma NN I-Lab_value
and CC O
necrosis NN B-Lab_value
. . O

Acid NNP B-Lab_value
- : I-Lab_value
fast NN I-Lab_value
bacilli NN I-Lab_value
were VBD O
identified VBN O
as IN O
rifampicin NN B-Detailed_description
- : I-Detailed_description
susceptible JJ I-Detailed_description
M NNP I-Detailed_description
. . I-Detailed_description
tuberculosis NN I-Detailed_description
by IN O
real JJ B-Detailed_description
- : I-Detailed_description
time NN I-Detailed_description
PCR NNP B-Diagnostic_procedure
. . O

On IN O
postoperative JJ O
day NN O
65 CD O
, , O
the DT O
patient NN O
` `` O
s JJ O
status NN B-Diagnostic_procedure
worsened VBD B-Lab_value
with IN O
severe JJ B-Severity
hypoxemia NN B-Sign_symptom
, , O
shock NN B-Disease_disorder
unresponsive JJ O
to TO O
high VB B-Dosage
dose JJ I-Dosage
cathecolamines NNS B-Medication
, , O
and CC O
multiorgan JJ B-Disease_disorder
failure NN I-Disease_disorder
. . O

The DT O
patient NN O
died VBD O
on IN O
postoperative JJ O
day NN O
70 CD O
, , O
despite IN O
treatment NN O
combining VBG O
isoniazid NN B-Medication
, , O
rifampicin NN B-Medication
, , O
ethambutol NN B-Medication
, , O
and CC O
pyrazinamide NN B-Medication
. . O

Retrospective JJ O
real JJ B-Detailed_description
- : I-Detailed_description
time NN I-Detailed_description
PCR NNP B-Diagnostic_procedure
testing NN O
of IN O
the DT O
explanted JJ B-Detailed_description
lung NN I-Detailed_description
and CC O
BALs NNP B-Detailed_description
performed VBD I-Detailed_description
on IN I-Detailed_description
postoperative JJ I-Detailed_description
days NNS I-Detailed_description
1 CD I-Detailed_description
, , I-Detailed_description
7 CD I-Detailed_description
, , I-Detailed_description
and CC I-Detailed_description
21 CD I-Detailed_description
remained VBD O
negative JJ B-Lab_value
. . O

The DT O
organ JJ O
donor NN O
died VBD B-Detailed_description
of IN I-Detailed_description
posttraumatic JJ I-Detailed_description
intracerebral JJ I-Detailed_description
hemorrhage NN I-Detailed_description
. . O

He PRP O
was VBD O
a DT B-Detailed_description
47 CD I-Detailed_description
- : I-Detailed_description
year NN I-Detailed_description
- : I-Detailed_description
old JJ I-Detailed_description
man NN I-Detailed_description
with IN O
no DT B-Detailed_description
history NN I-Detailed_description
of IN I-Detailed_description
lung NN I-Detailed_description
disease NN I-Detailed_description
or CC I-Detailed_description
risk NN I-Detailed_description
factors NNS I-Detailed_description
for IN I-Detailed_description
tuberculosis NN I-Detailed_description
other JJ O
than IN O
chronic JJ B-Detailed_description
alcohol NN I-Detailed_description
use NN I-Detailed_description
and CC I-Detailed_description
smoking NN I-Detailed_description
. . O

TST JJ B-Detailed_description
results NNS I-Detailed_description
were VBD I-Detailed_description
not RB I-Detailed_description
available JJ I-Detailed_description
. . O

During IN O
hospitalization NN O
, , O
a DT O
lung NN B-Detailed_description
CT NNP I-Detailed_description
- : I-Detailed_description
scan JJ I-Detailed_description
showed VBD I-Detailed_description
no DT I-Detailed_description
signs NNS I-Detailed_description
of IN I-Detailed_description
active JJ I-Detailed_description
or CC I-Detailed_description
previous JJ I-Detailed_description
tuberculosis NN I-Detailed_description
and CC O
no DT B-Detailed_description
TST NNP I-Detailed_description
or CC I-Detailed_description
IGRA NNP I-Detailed_description
test NN I-Detailed_description
results NNS I-Detailed_description
were VBD I-Detailed_description
available JJ I-Detailed_description
. . O

Routine JJ O
cultures NNS B-Detailed_description
of IN I-Detailed_description
per IN I-Detailed_description
- : I-Detailed_description
transplantation NN I-Detailed_description
right RB I-Detailed_description
lung NN I-Detailed_description
biopsy NN I-Detailed_description
yielded VBN I-Detailed_description
Candida NNP I-Detailed_description
albicans NNS I-Detailed_description
. . O

Retrospective JJ O
M NNP B-Detailed_description
. . I-Detailed_description
tuberculosis NN I-Detailed_description
real JJ I-Detailed_description
- : I-Detailed_description
time NN I-Detailed_description
PCR NNP I-Detailed_description
yielded VBD I-Detailed_description
negative JJ I-Detailed_description
results NNS I-Detailed_description
on IN I-Detailed_description
the DT I-Detailed_description
left NN I-Detailed_description
and CC I-Detailed_description
right JJ I-Detailed_description
donor NN I-Detailed_description
- : I-Detailed_description
lung NN I-Detailed_description
biopsies NNS I-Detailed_description
. . O

Both DT B-Detailed_description
kidneys NNS I-Detailed_description
from IN O
the DT O
same JJ O
donor NN O
were VBD O
transplanted VBN B-Detailed_description
into IN I-Detailed_description
2 CD I-Detailed_description
other JJ I-Detailed_description
recipients NNS I-Detailed_description
. . O

Six CD B-Detailed_description
months NNS I-Detailed_description
after IN I-Detailed_description
transplantation NN I-Detailed_description
, , O
neither DT B-Detailed_description
of IN I-Detailed_description
the DT I-Detailed_description
kidney NN I-Detailed_description
recipients NNS I-Detailed_description
had VBD I-Detailed_description
developed VBN I-Detailed_description
any DT I-Detailed_description
signs NNS I-Detailed_description
or CC I-Detailed_description
symptoms NNS I-Detailed_description
suggestive CD I-Detailed_description
of IN I-Detailed_description
active JJ I-Detailed_description
tuberculosis NN I-Detailed_description
. . O

-DOCSTART- NN -X-

A DT O
56 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
presented VBN O
with IN O
a DT O
2 CD B-Duration
- : I-Duration
year NN I-Duration
history NN O
of IN O
dysphagia NN O
. . O

He PRP O
was VBD O
diagnosed VBN O
with IN O
a DT O
middle JJ B-Biological_structure
thoracic NN I-Biological_structure
oesophageal VBP B-Biological_structure
squamous JJ B-Disease_disorder
cell NN I-Disease_disorder
carcinoma NN I-Disease_disorder
by IN O
both DT O
a DT O
gastroscopy NN B-Diagnostic_procedure
and CC O
a DT O
biopsy NN B-Diagnostic_procedure
. . O

A DT O
chest NN B-Biological_structure
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
scan NN O
showed VBD O
an DT O
enlarged JJ B-Sign_symptom
azygos NN B-Biological_structure
vein NN I-Biological_structure
( ( O
a DT O
diameter NN O
of IN O
2 CD B-Distance
. . I-Distance
5 CD I-Distance
cm NN I-Distance
) ) O
that WDT O
was VBD O
a DT O
continuation NN B-Sign_symptom
of IN O
the DT O
IVC NNP B-Biological_structure
( ( O
Fig NNP O
. . O
1a CD O
, , O
b NN O
) ) O
. . O

A DT O
CT NNP B-Diagnostic_procedure
scan NN O
of IN O
the DT O
abdomen NNS B-Biological_structure
showed VBD O
a DT O
defect NN B-Sign_symptom
in IN O
the DT O
suprarenal JJ B-Biological_structure
segment NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
inferior JJ I-Biological_structure
vena NN I-Biological_structure
cava NN I-Biological_structure
and CC O
direct JJ B-Detailed_description
drainage NN B-Sign_symptom
of IN O
the DT O
hepatic JJ B-Biological_structure
vein NN I-Biological_structure
into IN O
the DT O
right JJ B-Biological_structure
atrium NN I-Biological_structure
. . O

After IN O
consultation NN O
with IN O
the DT O
thoracic NN B-Nonbiological_location
surgery NN I-Nonbiological_location
department NN I-Nonbiological_location
clinicians NNS I-Nonbiological_location
and CC O
the DT O
anaesthesiology NN B-Nonbiological_location
department NN I-Nonbiological_location
, , O
we PRP O
decided VBD O
to TO O
perform VB O
a DT O
McKeown NNP B-Detailed_description
oesophagectomy NN B-Therapeutic_procedure
. . O

The DT O
patient NN O
was VBD O
anaesthetised VBN B-Therapeutic_procedure
with IN O
a DT O
double JJ B-Detailed_description
- : I-Detailed_description
lumen NNS I-Detailed_description
tube VBP I-Detailed_description
and CC O
underwent VBP O
a DT O
standard JJ B-Detailed_description
posterolateral JJ B-Detailed_description
thoracotomy NN B-Therapeutic_procedure
by IN O
traditional JJ B-Detailed_description
open JJ I-Detailed_description
surgery NN I-Detailed_description
. . O

We PRP O
first RB O
performed VBD O
the DT O
jugular NN B-Biological_structure
and CC I-Biological_structure
femoral JJ I-Biological_structure
vein NN I-Biological_structure
percutaneous JJ B-Detailed_description
puncture NN I-Detailed_description
to TO O
create VB O
a DT O
veno JJ B-Therapeutic_procedure
- : I-Therapeutic_procedure
venous JJ I-Therapeutic_procedure
bypass NN I-Therapeutic_procedure
and CC O
then RB O
connected VBD O
the DT O
pressure NN B-Therapeutic_procedure
sensor NN I-Therapeutic_procedure
system NN I-Therapeutic_procedure
to TO O
the DT O
monitor NN O
. . O

The DT O
monitor NN O
displayed VBD O
the DT O
real JJ O
- : O
time NN O
pressure NN O
value NN O
of IN O
the DT O
jugular JJ O
vein NN O
and CC O
the DT O
femoral JJ O
vein NN O
. . O

Macroscopically RB B-Diagnostic_procedure
, , O
the DT O
diameter NN B-Diagnostic_procedure
of IN O
the DT O
azygos JJ B-Biological_structure
arch NN I-Biological_structure
was VBD O
approximately RB O
2 CD B-Distance
. . I-Distance
5 CD I-Distance
cm NN I-Distance
( ( O
Fig NNP O
. . O
1c CD O
) ) O
, , O
and CC O
the DT O
superior JJ B-Detailed_description
edge NN I-Detailed_description
of IN O
the DT O
tumour NN B-Sign_symptom
adhered VBD O
tightly RB O
to TO O
the DT O
arch NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
azygos JJ I-Biological_structure
vein NN I-Biological_structure
. . O

When WRB O
the DT O
arch NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
azygos JJ I-Biological_structure
vein NN I-Biological_structure
was VBD O
pulled VBN B-Therapeutic_procedure
with IN O
a DT O
rubber NN B-Detailed_description
hose NN I-Detailed_description
to TO O
dissociate VB O
it PRP O
from IN O
the DT O
carcinoma NN O
, , O
the DT O
monitor NN O
showed VBD O
that IN O
the DT O
femoral JJ B-Biological_structure
vein JJ I-Biological_structure
pressure NN B-Diagnostic_procedure
increased VBD B-Lab_value
to TO O
52 CD B-Lab_value
mmH2O NN I-Lab_value
; : O
the DT O
pressure NN O
returned VBN O
to TO O
a DT O
normal JJ B-Lab_value
value NN I-Lab_value
when WRB O
we PRP O
opened VBD O
the DT O
bypass NN O
between IN O
the DT O
femoral JJ O
vein NN O
and CC O
the DT O
jugular JJ O
vein NN O
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

The DT O
surgery NN O
was VBD O
performed VBN O
smoothly RB O
, , O
without IN O
injury NN B-Disease_disorder
to TO O
the DT O
azygos NN B-Biological_structure
vein NN I-Biological_structure
, , O
and CC O
the DT O
postoperative JJ B-Diagnostic_procedure
recovery NN I-Diagnostic_procedure
was VBD O
uneventful JJ B-Lab_value
. . O

The DT O
pathology NN B-Diagnostic_procedure
of IN O
the DT O
resected JJ B-Detailed_description
specimen NNS I-Detailed_description
showed VBD O
a DT O
poorly RB B-Lab_value
differentiated VBN I-Lab_value
squamous JJ B-Disease_disorder
cell NN I-Disease_disorder
carcinoma NN I-Disease_disorder
and CC O
no DT O
evidence NN O
of IN O
malignancy NN B-Sign_symptom
in IN O
15 CD B-Lab_value
of IN O
the DT O
lymph NN B-Biological_structure
nodes NNS I-Biological_structure
. . O

After IN O
5 CD B-Duration
months NNS I-Duration
of IN O
follow JJ O
- : O
up RB O
, , O
the DT O
patient NN O
was VBD O
asymptomatic JJ B-Sign_symptom
, , O
with IN O
no DT O
evidence NN O
of IN O
recurrent JJ B-Disease_disorder
disease NN I-Disease_disorder
either CC O
clinically RB O
or CC O
on IN O
CT NNP B-Diagnostic_procedure
. . O

-DOCSTART- NN -X-

A DT O
58 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
with IN O
a DT O
past JJ O
medical JJ O
history NN O
of IN O
poorly RB B-Detailed_description
controlled VBN I-Detailed_description
hypertension NN O
and CC O
type NN O
2 CD O
diabetes NNS O
, , O
presented VBN O
to TO O
the DT O
ICU NNP B-Nonbiological_location
for IN O
a DT O
cardiogenic JJ B-Disease_disorder
shock NN I-Disease_disorder
complicating VBG O
acute JJ B-Detailed_description
myocardial JJ B-Disease_disorder
infarction NN I-Disease_disorder
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
reduced JJ B-Lab_value
level NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
consciousness NN I-Diagnostic_procedure
( ( O
Glasgow NNP B-Diagnostic_procedure
Coma NNP I-Diagnostic_procedure
Scale NNP I-Diagnostic_procedure
10 CD B-Lab_value
/ NNP I-Lab_value
15 CD I-Lab_value
) ) O
and CC O
weak JJ B-Lab_value
vital JJ B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
; : O
a DT O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN O
80 CD B-Lab_value
/ JJ I-Lab_value
50 CD I-Lab_value
mmHg NN I-Lab_value
, , O
80 CD B-Lab_value
% NN I-Lab_value
of IN O
oxygen NN B-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
, , O
capillary JJ B-Detailed_description
blood NN B-Diagnostic_procedure
glucose NN I-Diagnostic_procedure
at IN O
2 CD B-Lab_value
. . I-Lab_value
26 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
a DT O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
over IN B-Lab_value
125 CD I-Lab_value
bpm NNS I-Lab_value
, , O
and CC O
crackling VBG B-Sign_symptom
in IN O
pulmonary JJ B-Diagnostic_procedure
auscultation NN I-Diagnostic_procedure
. . O

Cardiovascular JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
neither CC O
cardiac JJ B-Sign_symptom
murmur NN I-Sign_symptom
nor CC O
signs NNS B-Sign_symptom
of IN I-Sign_symptom
right JJ I-Sign_symptom
heart NN I-Sign_symptom
failure NN I-Sign_symptom
. . O

ECG NNP B-Diagnostic_procedure
on IN O
admission NN O
showed VBD O
normal JJ B-Lab_value
sinus NN B-Detailed_description
rhythm NN B-Diagnostic_procedure
, , O
with IN O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
125 CD B-Lab_value
bpm NN I-Lab_value
and CC O
extended VBD B-Sign_symptom
ST NNP I-Sign_symptom
- : I-Sign_symptom
elevation NN I-Sign_symptom
in IN O
anterior JJ B-Detailed_description
territory NN I-Detailed_description
. . O

Laboratory NN B-Diagnostic_procedure
results NNS I-Diagnostic_procedure
demonstrated VBD O
Troponin NNP B-Diagnostic_procedure
I PRP I-Diagnostic_procedure
level VBP O
of IN O
6 CD B-Lab_value
. . I-Lab_value
41 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
, , O
creatinine JJ B-Diagnostic_procedure
kinase NN I-Diagnostic_procedure
( ( O
CKMB NNP B-Diagnostic_procedure
) ) O
was VBD O
67 CD B-Lab_value
UI NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
Lactate NNP B-Diagnostic_procedure
deshydrogenase NN I-Diagnostic_procedure
was VBD O
281 CD B-Lab_value
UI NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
glucose VBD B-Diagnostic_procedure
level JJ O
2 CD B-Lab_value
. . I-Lab_value
70 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
l NN I-Lab_value
, , O
urea JJ B-Diagnostic_procedure
0 CD B-Lab_value
. . I-Lab_value
40 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
l NN I-Lab_value
and CC O
creatinine NN B-Diagnostic_procedure
18 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
. . O

The DT O
patient NN O
was VBD O
intubated VBN B-Therapeutic_procedure
and CC O
sedated VBN B-Therapeutic_procedure
, , O
inotropic JJ B-Medication
agents NNS I-Medication
were VBD O
started VBN O
( ( O
norepinephrine JJ B-Medication
0 CD B-Dosage
. . I-Dosage
4µg CD I-Dosage
/ JJ I-Dosage
kg NN I-Dosage
/ NNP I-Dosage
min NN I-Dosage
and CC O
dobutamine VB B-Medication
20µg CD B-Dosage
/ NNP I-Dosage
kg NN I-Dosage
/ NNP I-Dosage
min NN I-Dosage
) ) O
. . O

Chest NNP B-Biological_structure
X NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
rays NNS I-Diagnostic_procedure
showed VBD O
diffuse IN B-Detailed_description
alveolar JJ B-Disease_disorder
syndrome NN I-Disease_disorder
. . O

Transthoracic NNP B-Biological_structure
echocardiography NN B-Diagnostic_procedure
revealed VBD O
wall JJ B-Sign_symptom
motion NN I-Sign_symptom
abnormalities NNS I-Sign_symptom
namely RB O
extensive JJ B-Severity
akinesis NN B-Sign_symptom
of IN O
anteroseptal JJ B-Biological_structure
, , O
anterior JJ B-Biological_structure
, , O
lateral JJ B-Biological_structure
and CC O
inferior JJ B-Biological_structure
walls NNS B-Biological_structure
, , O
and CC O
severe JJ B-Severity
left VBD B-Sign_symptom
ventricular JJ I-Sign_symptom
systolic JJ I-Sign_symptom
dysfunction NN I-Sign_symptom
( ( O
ejection JJ B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
of IN O
29 CD B-Lab_value
% NN I-Lab_value
) ) O
. . O

Medical JJ B-Therapeutic_procedure
management NN I-Therapeutic_procedure
was VBD O
initiated VBN O
; : O
anticoagulant JJ B-Medication
therapy NN O
for IN O
acute JJ B-Disease_disorder
coronary JJ I-Disease_disorder
syndrome NN I-Disease_disorder
was VBD O
started VBN O
( ( O
500 CD B-Dosage
mg NN I-Dosage
of IN O
acetylsalicylic JJ B-Medication
acid NN I-Medication
and CC O
subcutaneous JJ O
low JJ B-Medication
- : I-Medication
molecular JJ I-Medication
- : I-Medication
weight NN I-Medication
heparin NN I-Medication
( ( O
0 CD B-Dosage
. . I-Dosage
6 CD I-Dosage
ml NN I-Dosage
of IN O
enoxaparin NN B-Medication
) ) O
) ) O
and CC O
patient NN O
was VBD O
prepared VBN O
for IN O
myocardial JJ B-Therapeutic_procedure
revascularization NN I-Therapeutic_procedure
by IN O
coronary JJ B-Biological_structure
angioplasty NN B-Therapeutic_procedure
. . O

Because IN O
of IN O
non JJ B-Lab_value
- : I-Lab_value
improvement NN I-Lab_value
of IN O
neurological JJ B-Diagnostic_procedure
status NN I-Diagnostic_procedure
and CC O
occurrence NN O
of IN O
seizures NNS B-Sign_symptom
, , O
a DT O
brain NN B-Biological_structure
CT NNP B-Diagnostic_procedure
was VBD O
indicated VBN O
and CC O
revealed VBN O
infratentorial JJ B-Biological_structure
diffuse NN B-Detailed_description
hemorrhage NN B-Sign_symptom
( ( O
Fisher NNP B-Diagnostic_procedure
grade VB I-Diagnostic_procedure
III NNP B-Lab_value
) ) O
( ( O
Figure NNP O
1 CD O
) ) O
. . O

Cerebral JJ B-Biological_structure
angiography NN B-Diagnostic_procedure
confirmed VBD O
a DT O
dissecting VBG B-Disease_disorder
aneurysm NN I-Disease_disorder
of IN O
an DT O
anastomotic JJ B-Biological_structure
branch NN I-Biological_structure
between IN O
left VBN B-Biological_structure
PICA NNP I-Biological_structure
and CC O
the DT O
V4 NNP B-Biological_structure
segment NN I-Biological_structure
of IN I-Biological_structure
left JJ I-Biological_structure
vertebral JJ I-Biological_structure
artery NN I-Biological_structure
Figure NN O
2 CD O
that WDT O
was VBD O
successfully RB O
embolized VBN B-Therapeutic_procedure
. . O

After IN O
24 CD O
hours NNS O
, , O
the DT O
patient NN O
improved VBN B-Sign_symptom
with IN O
withdrawal NN O
of IN O
vasoactive JJ B-Medication
drugs NNS I-Medication
in IN O
24 CD O
hours NNS O
. . O

Left NNP B-Biological_structure
hemicorporeal NN I-Biological_structure
seizures NNS B-Sign_symptom
persisted VBD O
despite IN O
anticonvulsant JJ B-Medication
treatment NN O
. . O

Control NNP O
brain NN B-Biological_structure
CT NNP B-Diagnostic_procedure
did VBD O
not RB O
report VB O
rebleeding VBG B-Sign_symptom
and CC O
angiography NN B-Diagnostic_procedure
showed VBD O
complete JJ O
exclusion NN O
of IN O
the DT O
aneurysm NN B-Disease_disorder
while IN O
the DT O
EEG NNP B-Diagnostic_procedure
revealed VBD O
a DT O
diffuse NN B-Detailed_description
brain NN B-Disease_disorder
damage NN I-Disease_disorder
. . O

10 CD O
days NNS O
after IN O
admission NN O
, , O
the DT O
patient NN O
was VBD O
discharged VBN O
in IN O
stable JJ B-Lab_value
condition NN B-Diagnostic_procedure
but CC O
still RB O
suffers NNS O
from IN O
amnesia NN B-Disease_disorder
. . O

-DOCSTART- NN -X-

A DT B-Age
49 CD I-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
, , O
with IN O
no DT O
history NN O
of IN O
cardiac JJ O
disease NN O
, , O
presented VBN O
with IN O
progressive JJ B-Detailed_description
dyspnea NN B-Sign_symptom
of IN O
one CD B-Duration
month NN I-Duration
` `` I-Duration
s JJ I-Duration
duration NN I-Duration
. . O

Medical JJ O
History NNP O
. . O

His PRP$ O
medical JJ O
history NN O
included VBD O
blunt NN B-Detailed_description
chest NN B-Biological_structure
trauma NN B-Disease_disorder
, , O
the DT O
result NN O
of IN O
an DT O
accidental JJ B-Activity
fall NN I-Activity
from IN O
scaffolding VBG O
15 CD O
months NNS O
earlier RB O
. . O

He PRP O
had VBD O
fallen VBN O
approximately RB O
8 CD O
feet NNS O
and CC O
had VBD O
landed VBN O
on IN O
the DT O
right JJ O
side NN O
of IN O
his PRP$ O
back NN O
and CC O
on IN O
his PRP$ O
right JJ O
shoulder NN O
. . O

The DT O
patient NN O
had VBD O
sustained VBN O
bilateral JJ B-Detailed_description
pneumothorax NN B-Sign_symptom
, , O
right JJ B-Biological_structure
iliopsoas NN I-Biological_structure
muscle NN I-Biological_structure
hematoma NN B-Sign_symptom
, , O
multiple JJ B-Detailed_description
right JJ B-Biological_structure
costal NN I-Biological_structure
fractures NNS B-Sign_symptom
, , O
fracture NN B-Sign_symptom
of IN O
the DT O
L3 NNP B-Biological_structure
vertebral JJ I-Biological_structure
body NN I-Biological_structure
and CC O
the DT O
transverse NN B-Biological_structure
process NN I-Biological_structure
, , O
and CC O
displaced VBD B-Detailed_description
fractures NNS B-Sign_symptom
of IN O
the DT O
right JJ B-Biological_structure
clavicle NN I-Biological_structure
. . O

That DT O
hospitalization NN O
had VBD O
lasted VBN O
40 CD B-Duration
days NNS I-Duration
, , O
during IN O
which WDT O
time NN O
the DT O
clinicians NNS O
had VBD O
not RB O
detected VBN O
any DT O
murmur NN B-Sign_symptom
or CC O
requested VBD O
a DT O
cardiac JJ B-Diagnostic_procedure
evaluation NN I-Diagnostic_procedure
. . O

The DT O
patient NN O
returned VBD O
to TO O
normal JJ B-Activity
activities NNS I-Activity
4 CD O
weeks NNS O
after IN O
discharge NN O
from IN O
the DT O
hospital NN B-Nonbiological_location
and CC O
remained VBD O
asymptomatic JJ B-Sign_symptom
for IN O
one CD B-Duration
year NN I-Duration
. . O

Upon IN O
his PRP$ O
arrival NN O
at IN O
our PRP$ O
department NN B-Nonbiological_location
, , O
auscultation NN B-Diagnostic_procedure
revealed VBD O
bibasilar JJ B-Detailed_description
rales NNS B-Sign_symptom
and CC O
a DT O
pansystolic JJ B-Detailed_description
murmur NN B-Sign_symptom
. . O

Chest NNP B-Biological_structure
radiography NN B-Diagnostic_procedure
showed VBD O
mild JJ B-Severity
lung JJ B-Biological_structure
congestion NN B-Sign_symptom
; : O
and CC O
transthoracic VB B-Biological_structure
echocardiography NN B-Diagnostic_procedure
, , O
limited VBN B-Detailed_description
by IN I-Detailed_description
suboptimal JJ I-Detailed_description
acoustic JJ I-Detailed_description
windows NNS I-Detailed_description
, , O
revealed VBD O
severe RB B-Severity
, , O
eccentric JJ B-Detailed_description
mitral JJ B-Sign_symptom
regurgitation NN I-Sign_symptom
. . O

The DT O
valvular NN B-Biological_structure
and CC O
subvalvular JJ B-Biological_structure
apparatus NN I-Biological_structure
appeared VBD O
to TO O
be VB O
structurally RB B-Sign_symptom
normal JJ I-Sign_symptom
, , O
and CC O
the DT O
left JJ B-Biological_structure
atrium NN I-Biological_structure
was VBD O
only RB O
mildly RB B-Severity
dilated VBN B-Sign_symptom
. . O

The DT O
patient NN O
was VBD O
treated VBN O
with IN O
intravenous JJ O
diuretics NNS B-Medication
until IN O
the DT O
signs NNS B-Sign_symptom
and CC I-Sign_symptom
symptoms NNS I-Sign_symptom
of IN I-Sign_symptom
congestion NN I-Sign_symptom
were VBD O
relieved VBN O
. . O

Coronary JJ B-Biological_structure
angiography NN B-Diagnostic_procedure
revealed VBD O
an DT O
absence NN O
of IN O
substantial JJ O
coronary JJ B-Disease_disorder
disease NN I-Disease_disorder
. . O

We PRP O
therefore RB O
planned VBD O
an DT O
elective JJ O
surgical JJ O
procedure NN O
for IN O
mitral JJ B-Therapeutic_procedure
valve NN I-Therapeutic_procedure
repair NN I-Therapeutic_procedure
. . O

Surgical JJ O
Procedure NN O
. . O

During IN O
intraoperative JJ B-Detailed_description
transesophageal NN B-Diagnostic_procedure
echocardiography NN I-Diagnostic_procedure
( ( O
TEE NNP B-Diagnostic_procedure
) ) O
, , O
we PRP O
observed VBD O
both DT O
a DT O
trivial JJ B-Severity
central JJ B-Detailed_description
mitral JJ B-Sign_symptom
regurgitant NN I-Sign_symptom
jet NN I-Sign_symptom
and CC O
a DT O
severe JJ B-Severity
perivalvular NN B-Sign_symptom
regurgitant NN I-Sign_symptom
jet NN I-Sign_symptom
, , O
this DT O
last JJ O
originating NN O
from IN O
a DT O
ventriculoatrial JJ B-Biological_structure
fistulous JJ B-Sign_symptom
communication NN I-Sign_symptom
behind IN B-Biological_structure
the DT I-Biological_structure
P1 NNP I-Biological_structure
scallop NN I-Biological_structure
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Further JJ O
examination NN O
confirmed VBD O
the DT O
absence NN O
of IN O
structural JJ B-Disease_disorder
disease NN I-Disease_disorder
involving VBG O
the DT O
mitral JJ B-Biological_structure
leaflets NNS I-Biological_structure
or CC O
subvalvular JJ B-Biological_structure
apparatus NN I-Biological_structure
. . O

After IN O
surgical JJ B-Therapeutic_procedure
exposure NN I-Therapeutic_procedure
of IN O
the DT O
mitral JJ B-Biological_structure
valve NN I-Biological_structure
, , O
a DT O
small JJ B-Lab_value
tear NN B-Sign_symptom
( ( O
length NN B-Distance
, , I-Distance
6 CD I-Distance
- : I-Distance
7 CD I-Distance
mm NN I-Distance
) ) O
could MD O
be VB O
seen VBN O
behind IN B-Biological_structure
the DT I-Biological_structure
posterior JJ I-Biological_structure
leaflet NN I-Biological_structure
, , O
in IN O
a DT O
lateral JJ B-Detailed_description
position NN I-Detailed_description
, , O
involving VBG O
also RB O
the DT O
annulus NN B-Biological_structure
and CC O
the DT O
left JJ B-Biological_structure
atrial JJ I-Biological_structure
wall NN I-Biological_structure
. . O

The DT O
absence NN O
of IN O
leaflet NN B-Biological_structure
abnormalities NNS B-Sign_symptom
or CC O
vegetations NNS B-Sign_symptom
suggested VBD O
the DT O
posttraumatic JJ B-Detailed_description
origin NN I-Detailed_description
of IN O
the DT O
perivalvular JJ B-Sign_symptom
leak NN I-Sign_symptom
. . O

Valvular NNP B-Therapeutic_procedure
repair NN I-Therapeutic_procedure
was VBD O
successfully RB O
achieved VBN O
by IN O
direct JJ O
suture NN B-Therapeutic_procedure
of IN O
the DT O
tear NN O
with IN O
three CD B-Detailed_description
5 CD B-Detailed_description
- : I-Detailed_description
0 CD I-Detailed_description
Prolene NNP I-Detailed_description
stitches NNS B-Therapeutic_procedure
and CC O
by IN O
the DT O
subsequent JJ O
insertion NN O
of IN O
a DT O
30 CD B-Distance
- : I-Distance
mm NN I-Distance
mitral JJ B-Therapeutic_procedure
annuloplasty JJ I-Therapeutic_procedure
ring NN I-Therapeutic_procedure
. . O

The DT O
patient NN O
was VBD O
extubated VBN B-Therapeutic_procedure
the DT O
next JJ O
day NN O
and CC O
his PRP$ O
postsurgical JJ B-Therapeutic_procedure
course NN I-Therapeutic_procedure
was VBD O
uncomplicated JJ B-Lab_value
. . O

One CD O
year NN O
later RB O
, , O
he PRP O
was VBD O
asymptomatic JJ B-Sign_symptom
, , O
and CC O
his PRP$ O
one CD O
- : O
year NN O
follow SYM O
- : O
up RB O
transthoracic JJ B-Biological_structure
echocardiogram NN B-Diagnostic_procedure
confirmed VBD B-Lab_value
the DT I-Lab_value
excellent JJ I-Lab_value
result NN I-Lab_value
of IN O
his PRP$ O
surgical JJ O
treatment NN O
. . O

-DOCSTART- NN -X-

A DT O
66 CD B-Age
year NN I-Age
old JJ I-Age
patient NN O
with IN O
a DT O
history NN O
of IN O
UC NNP O
treated VBN O
by IN O
mesalazine NN B-Medication
since IN B-Duration
5 CD I-Duration
years NNS I-Duration
consulted VBN O
in IN O
July NNP O
2012 CD O
for IN O
a DT O
painful JJ B-Detailed_description
erythematous JJ B-Detailed_description
swelling NN B-Sign_symptom
of IN O
the DT O
back NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
hand NN I-Biological_structure
. . O

The DT O
bacteriological JJ B-Diagnostic_procedure
samples NNS I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
, , O
the DT O
lesion NN O
was VBD O
considered VBN O
as IN O
an DT O
abscesses NNS B-Sign_symptom
and CC O
the DT O
patient NN O
was VBD O
treated VBN O
with IN O
antibiotics NNS B-Medication
and CC O
local JJ B-Medication
antiseptics NNS I-Medication
without IN O
improvement NN B-Sign_symptom
. . O

The DT O
evolution NN O
was VBD O
characterized VBN O
by IN O
the DT O
appearance NN O
of IN O
an DT O
erythematous JJ B-Detailed_description
vesiculobullous JJ B-Detailed_description
centrifugal JJ B-Sign_symptom
expansion NN I-Sign_symptom
taking VBG O
the DT O
whole JJ B-Biological_structure
back NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
hand NN I-Biological_structure
treated VBD O
several JJ B-Frequency
times NNS I-Frequency
by IN O
various JJ B-Medication
antibiotics NNS I-Medication
unsuccessfully RB O
. . O

Biopsy NNP B-Diagnostic_procedure
of IN O
this DT O
lesion NN O
was VBD O
initially RB O
not RB B-Lab_value
specific JJ I-Lab_value
. . O

In IN O
October NNP O
2012 CD O
, , O
the DT O
patient NN O
was VBD O
hospitalized VBN O
for IN O
fever NN B-Sign_symptom
and CC O
polyarthralgia NN B-Sign_symptom
in IN O
the DT O
context NN O
of IN O
impaired JJ B-Sign_symptom
general JJ I-Sign_symptom
condition NN I-Sign_symptom
. . O

He PRP O
had VBD O
a DT O
quiescent JJ B-Detailed_description
UC NNP B-Disease_disorder
disease NN I-Disease_disorder
. . O

The DT O
skin NN B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
found VBD O
an DT O
erythematous JJ B-Detailed_description
plaque NN B-Sign_symptom
of IN O
10 CD B-Distance
cm NN I-Distance
of IN O
diameter NN O
, , O
with IN O
a DT O
raised VBN B-Detailed_description
border NN I-Detailed_description
and CC O
vesicules NNS B-Detailed_description
, , O
taking VBG O
the DT O
back NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
hand NN I-Biological_structure
and CC O
wrist NN B-Biological_structure
( ( O
Figure NNP O
1 CD O
) ) O
. . O

There EX O
was VBD O
also RB O
an DT O
infiltrated JJ B-Detailed_description
erythematous JJ B-Detailed_description
plaque NN B-Sign_symptom
on IN O
the DT O
right JJ B-Biological_structure
leg NN I-Biological_structure
( ( O
Figure NNP O
2 CD O
) ) O
and CC O
another DT O
topped VBN B-Detailed_description
with IN I-Detailed_description
a DT I-Detailed_description
large JJ I-Detailed_description
pustule NN I-Detailed_description
at IN O
the DT O
left NN B-Biological_structure
ankle NN I-Biological_structure
( ( O
Figure NNP O
3 CD O
) ) O
. . O

In IN O
biology NN O
, , O
there EX O
was VBD O
a DT O
biological JJ B-Disease_disorder
inflammatory NN I-Disease_disorder
syndrome NN I-Disease_disorder
and CC O
high JJ B-Severity
leukocytosis NN B-Sign_symptom
with IN B-Detailed_description
neutrophils NNS I-Detailed_description
. . O

Hepatic NNP B-Diagnostic_procedure
and CC O
renal JJ B-Diagnostic_procedure
functions NNS I-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

Skin NNP B-Diagnostic_procedure
biopsy NN I-Diagnostic_procedure
showed VBD O
at IN O
the DT O
edge NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
back NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
closet NN I-Biological_structure
right JJ I-Biological_structure
hand NN I-Biological_structure
ulcerated VBD B-Sign_symptom
epidermis NN I-Sign_symptom
and CC O
the DT O
dermis NN B-Detailed_description
infiltrate NN I-Detailed_description
rich JJ I-Detailed_description
in IN I-Detailed_description
neutrophils NNS I-Detailed_description
with IN O
leukocytoclastic JJ B-Detailed_description
vasculitis NN B-Sign_symptom
finding VBG O
a DT O
PG NNP B-Disease_disorder
( ( O
Figure NNP O
4 CD O
) ) O
. . O

Other JJ B-Diagnostic_procedure
biopsies NNS I-Diagnostic_procedure
taken VBN O
at IN O
infiltrated JJ B-Detailed_description
erythematous JJ B-Detailed_description
plaques NNS B-Sign_symptom
of IN O
the DT O
ankle NN B-Biological_structure
showed VBD O
a DT O
normal JJ B-Lab_value
appearance NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
skin NN I-Diagnostic_procedure
, , O
edema NN B-Sign_symptom
of IN O
the DT O
superficial JJ B-Biological_structure
dermis NN I-Biological_structure
based VBN O
on IN O
an DT O
infiltrate NN B-Detailed_description
rich NN I-Detailed_description
in IN I-Detailed_description
neutrophils NNS I-Detailed_description
without IN O
vasculitis NN B-Sign_symptom
confirming VBG O
the DT O
diagnosis NN O
of IN O
SS NNP B-Disease_disorder
( ( O
Figure NNP O
5 CD O
) ) O
. . O

Corticosteroid NNP B-Medication
treatment NN O
was VBD O
then RB O
started VBN O
with IN O
prednisolone NN B-Medication
at IN O
a DT O
dose NN O
of IN O
1 CD B-Dosage
mg NNS I-Dosage
/ JJ I-Dosage
Kg NNP I-Dosage
/ NNP I-Dosage
j NN I-Dosage
. . O

The DT O
evolution NN O
was VBD O
marked VBN O
since IN O
day NN O
7 CD O
of IN O
treatment NN O
by IN O
the DT O
desinfiltration NN B-Sign_symptom
of IN I-Sign_symptom
the DT I-Sign_symptom
plaques NNS I-Sign_symptom
( ( O
Figure NNP O
6 CD O
) ) O
, , O
the DT O
recovery NN B-Sign_symptom
of IN I-Sign_symptom
the DT I-Sign_symptom
general JJ I-Sign_symptom
condition NN I-Sign_symptom
and CC O
disappearance NN O
of IN O
biological JJ B-Disease_disorder
inflammatory JJ I-Disease_disorder
syndrome NN I-Disease_disorder
. . O

-DOCSTART- NN -X-

A DT O
53 CD B-Age
year NN I-Age
old JJ I-Age
female NN O
without IN O
significant JJ O
past JJ O
medical JJ O
history NN O
developed VBN O
severe JJ B-Severity
viral JJ B-Detailed_description
pneumonia NN B-Disease_disorder
, , O
with IN O
rapid JJ B-Detailed_description
, , O
progressive JJ B-Detailed_description
deterioration NN B-Lab_value
in IN O
her PRP$ O
respiratory NN B-Diagnostic_procedure
status NN I-Diagnostic_procedure
. . O

She PRP O
developed VBD O
ARDS NNP B-Disease_disorder
and CC O
mechanical JJ B-Therapeutic_procedure
ventilatory NN I-Therapeutic_procedure
management NN I-Therapeutic_procedure
using VBG O
ARDS NNP B-Detailed_description
protocol NN I-Detailed_description
were VBD O
unable JJ B-Lab_value
to TO I-Lab_value
maintain VB I-Lab_value
adequate JJ I-Lab_value
oxygenation NN B-Diagnostic_procedure
. . O

As IN O
a DT O
result NN O
, , O
bedside NN B-Detailed_description
VV NNP B-Detailed_description
- : O
ECMO NN B-Therapeutic_procedure
was VBD O
planned VBN O
. . O

Transesophageal NNP B-Diagnostic_procedure
echocardiography NN I-Diagnostic_procedure
( ( O
TEE NNP B-Diagnostic_procedure
) ) O
was VBD O
performed VBN O
to TO O
visualize VB O
proper JJ O
positioning NN B-Therapeutic_procedure
of IN I-Therapeutic_procedure
the DT I-Therapeutic_procedure
guidewire NN I-Therapeutic_procedure
and CC O
cannula NN B-Therapeutic_procedure
. . O

Using VBG O
the DT O
Seldinger NNP B-Detailed_description
technique NN I-Detailed_description
, , O
the DT O
right JJ B-Biological_structure
internal JJ I-Biological_structure
jugular NN I-Biological_structure
vein NN I-Biological_structure
was VBD O
accessed VBN O
and CC O
a DT O
guide NN O
wire NN O
was VBD O
placed VBN O
. . O

Placement NN O
of IN O
the DT O
guidewire NN O
into IN O
the DT O
IVC NNP O
proved VBD O
difficult JJ O
due JJ O
to TO O
repeated JJ O
migration NN B-Detailed_description
of IN I-Detailed_description
the DT I-Detailed_description
guidewire NN I-Detailed_description
into IN O
the DT O
right JJ B-Biological_structure
ventricle NN I-Biological_structure
. . O

After IN O
multiple JJ O
attempts NNS O
, , O
the DT O
guidewire NN O
was VBD O
visualized VBN O
to TO O
course NN O
properly RB O
from IN O
the DT O
SVC NNP O
to TO O
the DT O
IVC NNP O
. . O

After IN O
a DT O
bolus NN B-Detailed_description
dose NN O
of IN O
5000 CD B-Dosage
units NNS I-Dosage
of IN O
intravenous JJ O
heparin NN B-Medication
was VBD O
given VBN O
, , O
the DT O
right JJ B-Biological_structure
internal JJ I-Biological_structure
jugular NN I-Biological_structure
venous JJ I-Biological_structure
access NN O
site NN O
was VBD O
dilated VBN B-Therapeutic_procedure
. . O

Just RB O
as IN O
the DT O
final JJ O
dilatation NN O
was VBD O
completed VBN O
and CC O
upon IN O
dilator JJ B-Therapeutic_procedure
exchange NN I-Therapeutic_procedure
with IN O
simultaneous JJ O
advancement NN O
of IN O
the DT O
23 CD B-Detailed_description
French JJ I-Detailed_description
Avalon NNP I-Detailed_description
cannula NN O
, , O
TEE NNP B-Diagnostic_procedure
lost VBD B-Lab_value
visualization NN I-Lab_value
of IN I-Lab_value
the DT I-Lab_value
guidewire NN I-Lab_value
. . O

Multiple JJ B-Detailed_description
premature NN B-Sign_symptom
ventricular JJ I-Sign_symptom
beats NNS I-Sign_symptom
were VBD O
noted VBN O
and CC O
immediately RB O
, , O
a DT O
new JJ O
, , O
rapidly RB B-Detailed_description
enlarging VBG I-Detailed_description
pericardial JJ B-Disease_disorder
effusion NN I-Disease_disorder
was VBD O
detected VBN O
( ( O
Figure NNP O
( ( O
Figure2 NNP O
) ) O
. . O
2 CD O
) ) O
. . O

Emergent JJ O
preparations NNS O
were VBD O
made VBN O
for IN O
bedside JJ O
surgical JJ B-Therapeutic_procedure
decompression NN I-Therapeutic_procedure
of IN O
the DT O
pericardial JJ B-Biological_structure
space NN I-Biological_structure
. . O

Quickly RB O
the DT O
patient NN O
lost VBD B-Lab_value
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
from IN O
acute JJ B-Detailed_description
cardiac JJ B-Disease_disorder
tamponade NN I-Disease_disorder
. . O

The DT O
Avalon NNP B-Detailed_description
cannula NN O
was VBD O
immediately RB O
clamped VBN B-Detailed_description
at IN I-Detailed_description
the DT I-Detailed_description
end NN I-Detailed_description
but CC I-Detailed_description
not RB I-Detailed_description
removed VBN I-Detailed_description
. . O

A DT O
emergent JJ O
subxiphoid NN B-Biological_structure
pericardial NN B-Therapeutic_procedure
window NN I-Therapeutic_procedure
was VBD O
performed VBN O
, , O
resulting VBG O
in IN O
drainage NN B-Sign_symptom
of IN O
venous JJ B-Biological_structure
blood NN I-Biological_structure
and CC O
restoration NN B-Lab_value
of IN O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
. . O

Transfusion NN B-Therapeutic_procedure
was VBD O
initiated VBN O
and CC O
the DT O
patient NN O
was VBD O
emergently RB O
transported VBN O
to TO O
the DT O
operating NN B-Nonbiological_location
room NN I-Nonbiological_location
for IN O
surgical JJ B-Diagnostic_procedure
exploration NN I-Diagnostic_procedure
. . O

The DT O
Avalon NNP B-Detailed_description
cannula NN O
was VBD O
found VBN O
to TO O
have VB O
perforated VBN B-Disease_disorder
the DT O
apex NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
ventricle NN I-Biological_structure
. . O

The DT O
injury NN O
was VBD O
repaired VBN B-Therapeutic_procedure
primarily RB O
and CC O
the DT O
Avalon NNP B-Detailed_description
cannula NN O
was VBD O
repositioned VBN O
toward IN O
the DT O
IVC NNP B-Biological_structure
again RB O
by IN O
TEE NNP B-Diagnostic_procedure
with IN O
additional JJ B-Detailed_description
direct JJ I-Detailed_description
manipulation NN I-Detailed_description
. . O

VV NNP B-Detailed_description
- : O
ECMO NN B-Therapeutic_procedure
was VBD O
initiated VBN O
and CC O
the DT O
oxygenation NN B-Diagnostic_procedure
improved VBD B-Lab_value
. . O

Due JJ O
to TO O
excessive JJ O
coagulopathies NNS B-Disease_disorder
, , O
the DT O
sternum NN B-Biological_structure
was VBD O
left VBN B-Therapeutic_procedure
open JJ I-Therapeutic_procedure
but CC O
was VBD O
closed VBN B-Therapeutic_procedure
on IN O
postoperative JJ O
day NN O
2 CD O
. . O

From IN O
that DT O
point NN O
, , O
she PRP O
remained VBD O
free JJ O
from IN O
any DT O
cardiac NN B-Biological_structure
or CC O
infectious JJ B-Detailed_description
complications NNS B-Sign_symptom
and CC O
her PRP$ O
pulmonary JJ B-Diagnostic_procedure
condition NN I-Diagnostic_procedure
slowly RB B-Lab_value
improved VBN I-Lab_value
. . O

She PRP O
was VBD O
successfully RB O
weaned VBN O
from IN O
VV NNP B-Detailed_description
- : O
ECMO NN B-Therapeutic_procedure
on IN O
postoperative JJ O
day NN O
9 CD O
and CC O
was VBD O
discharged VBN O
home NN B-Nonbiological_location
on IN O
postoperative JJ O
day NN O
24 CD O
without IN O
the DT O
need NN O
for IN O
home NN B-Therapeutic_procedure
oxygen NN I-Therapeutic_procedure
. . O

She PRP O
regained VBD O
full JJ B-Lab_value
physical JJ B-Diagnostic_procedure
functions NNS I-Diagnostic_procedure
at IN O
home NN O
and CC O
recovered VBD O
normal JJ B-Lab_value
pulmonary JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
by IN O
3 CD O
months NNS O
following VBG O
discharge NN O
from IN O
the DT O
hospital NN B-Nonbiological_location
. . O

-DOCSTART- NN -X-

A DT O
46 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Caucasian JJ O
woman NN O
with IN O
type JJ O
2 CD O
diabetes NNS O
mellitus NN O
and CC O
bipolar JJ O
disorder NN O
presented VBD O
to TO O
our PRP$ O
emergency NN B-Nonbiological_location
department NN I-Nonbiological_location
with IN O
vague JJ B-Detailed_description
abdominal JJ B-Sign_symptom
symptoms NNS I-Sign_symptom
and CC O
vomiting NN B-Sign_symptom
. . O

Her PRP$ O
pertinent JJ O
history NN O
includes VBZ O
left VBN O
below IN O
knee NN O
amputation NN O
and CC O
right NN O
toes NNS O
amputation NN O
for IN O
complications NNS O
secondary JJ O
to TO O
diabetic JJ O
neuropathy NN O
. . O

At IN O
the DT O
time NN O
of IN O
admission NN O
, , O
she PRP O
was VBD O
undergoing VBG O
care NN O
for IN O
an DT O
infected JJ B-Detailed_description
diabetic JJ B-Detailed_description
ulcer NN B-Sign_symptom
of IN O
her PRP$ O
right JJ B-Biological_structure
foot NN I-Biological_structure
. . O

Of IN O
note NN O
, , O
she PRP O
did VBD O
not RB O
have VB O
a DT O
history NN O
of IN O
CAPD NNP B-Disease_disorder
or CC O
a DT O
history NN O
of IN O
renal JJ B-Disease_disorder
disease NN I-Disease_disorder
: : O
creatinine NN B-Diagnostic_procedure
1 CD B-Lab_value
. . I-Lab_value
23 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
blood NN B-Diagnostic_procedure
urea JJ I-Diagnostic_procedure
nitrogen NN I-Diagnostic_procedure
( ( B-Diagnostic_procedure
BUN NNP I-Diagnostic_procedure
) ) I-Diagnostic_procedure
16 CD B-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
. . O

Her PRP$ O
blood NN B-Diagnostic_procedure
glucose NN I-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
were VBD O
poorly RB B-Lab_value
controlled VBN I-Lab_value
via IN O
subcutaneous JJ O
insulin NN B-Medication
injection NN O
; : O
she PRP O
reported VBD O
a DT O
range NN B-Lab_value
of IN I-Lab_value
400 CD I-Lab_value
to TO I-Lab_value
500 CD I-Lab_value
mg NNS I-Lab_value
/ JJ I-Lab_value
dL NN I-Lab_value
at IN I-Lab_value
home NN I-Lab_value
( ( O
due JJ O
to TO O
poor JJ O
drug NN O
compliance NN O
) ) O
. . O

Her PRP$ O
blood NN B-Diagnostic_procedure
glucose NN I-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
were VBD O
decreased VBN O
to TO O
a DT O
range NN O
of IN O
175 CD B-Lab_value
to TO I-Lab_value
378 CD I-Lab_value
mg NNS I-Lab_value
/ JJ I-Lab_value
dL NN I-Lab_value
after IN O
implementation NN O
of IN O
a DT O
stricter NN B-Detailed_description
insulin NN B-Medication
regimen NNS B-Detailed_description
upon IN O
admission NN O
. . O

A DT O
non JJ B-Detailed_description
- : I-Detailed_description
contrast NN I-Detailed_description
CT NNP B-Diagnostic_procedure
scan JJ I-Diagnostic_procedure
showed VBD O
confluent NN B-Detailed_description
, , O
bilobar NN B-Biological_structure
geographic JJ O
regions NNS O
of IN O
hypoattenuation NN B-Sign_symptom
in IN O
a DT O
subcapsular JJ B-Detailed_description
distribution NN I-Detailed_description
throughout IN O
her PRP$ O
liver NN B-Biological_structure
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

A DT O
MRI NNP B-Diagnostic_procedure
liver NN B-Biological_structure
protocol NN O
was VBD O
performed VBN O
for IN O
further JJ O
evaluation NN O
of IN O
these DT O
indeterminate JJ O
findings NNS O
to TO O
assess VB O
for IN O
possible JJ O
vascular JJ O
etiology NN O
as IN O
areas NNS O
of IN O
infarction NN O
could MD O
also RB O
be VB O
possible JJ O
in IN O
this DT O
patient NN O
. . O

In IN B-Detailed_description
- : I-Detailed_description
phase NN I-Detailed_description
gradient NN B-Diagnostic_procedure
echo NN I-Diagnostic_procedure
images NNS O
demonstrated VBD O
hyperintense JJ B-Detailed_description
foci NN B-Sign_symptom
in IN O
her PRP$ O
liver NN B-Biological_structure
in IN O
a DT O
distribution NN O
corresponding VBG O
to TO O
the DT O
hypoattenuating NN O
regions NNS O
seen VBN O
on IN O
CT NNP O
. . O

On IN O
the DT O
opposed JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
phase NN I-Diagnostic_procedure
sequence NN I-Diagnostic_procedure
, , O
there EX O
was VBD O
loss NN B-Lab_value
in IN I-Lab_value
signal NN I-Lab_value
within IN O
these DT O
areas NNS O
indicating VBG O
the DT O
presence NN B-Sign_symptom
of IN I-Sign_symptom
intracellular JJ I-Sign_symptom
fat NN I-Sign_symptom
and CC I-Sign_symptom
water NN I-Sign_symptom
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

In IN O
addition NN O
, , O
these DT O
areas NNS O
were VBD O
hypointense NN O
to TO O
the DT O
remaining VBG O
hepatic JJ B-Biological_structure
parenchyma NN I-Biological_structure
on IN O
the DT O
fat JJ O
suppression NN O
MR NNP O
sequences NNS O
, , O
confirming VBG O
presence NN B-Sign_symptom
of IN I-Sign_symptom
fat JJ I-Sign_symptom
and CC O
thus RB O
establishing VBG O
a DT O
diagnosis NN O
of IN O
SHS NNP B-Disease_disorder
. . O

Furthermore RB O
, , O
a DT O
follow NN O
- : O
up RB O
CT NNP B-Diagnostic_procedure
of IN O
her PRP$ O
abdomen NNS B-Biological_structure
and CC O
pelvis NN B-Biological_structure
was VBD O
performed VBN O
3 CD O
months NNS O
later RB O
, , O
which WDT O
showed VBD O
near IN B-Sign_symptom
complete JJ I-Sign_symptom
resolution NN I-Sign_symptom
of IN O
these DT O
findings NNS O
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

Of IN O
note NN O
, , O
stricter JJR O
glucose VB B-Therapeutic_procedure
control NN I-Therapeutic_procedure
had VBD O
decreased VBN O
her PRP$ O
average JJ O
blood NN B-Diagnostic_procedure
glucose JJ I-Diagnostic_procedure
level NN I-Diagnostic_procedure
to TO O
below IN B-Lab_value
200 CD I-Lab_value
mg NNS I-Lab_value
/ JJ I-Lab_value
dL NN I-Lab_value
. . O

